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CHAPTER 1 
Introduction 
Muscle Metaboreflex: the Afferent Arm   
Skeletal muscle is extensively innervated with afferent sensory nerve fibers 
which communicate information to the central nervous system (CNS) regarding its 
relative state or condition.  Skeletal muscle afferents refer to signals emerging from 
encapsulated skeletal muscle structures such as muscle spindles and Golgi tendon 
organs (i.e., proprioceptors) which relay proprioceptive information (e.g., muscle 
position, tension and rate of length change) to the CNS by way of group I and II afferent 
fibers.  In addition, skeletal muscle afferents relay “chemical” and “mechanical” 
information to the CNS regarding the current state of its interstitial chemical milieu and 
physical stress associated with muscle work (20; 79).  These types of signals are 
collectively and aptly referred to as ergoceptive information emerging from 
encapsulated, free nerve endings within skeletal muscle (i.e., ergoceptors) and are 
carried by neurons classified as group III and IV afferent fibers (76).   
In a classic series of human experiments by Alam and Smirk (4; 5), they 
discovered that exercise during complete circulatory occlusion (i.e., ischemic exercise) 
evoked marked elevations in blood pressure and heart rate (HR) that were sustained 
upon cessation of the exercise so long as the blood flow to the exercising muscle 
remained arrested.  The absence of arterial inflow to and venous outflow from the 
muscle effectively eliminated the potential for endocrine communication between the 
muscle and the CNS.  As a result, they concluded that the observed reflex response 
must be neurogenic and that the stimulus initiating and sustaining the reflex was the 
accumulation of metabolites within the muscle.  Although the findings of their initial 
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experiments were purely serendipitous, their studies are regarded as the pioneering 
work demonstrating the presence of such a ‘muscle metabolite’ reflex.  Following up on 
this work, Asmussen and Nielsen (11) produced similar results in dynamic exercising 
humans, however in addition to suggesting muscle chemoreceptors they also implicated 
muscle mechanoreceptors as the potential source of the reflex pressor response.  
Subsequent animal experiments by Coote and Perez-Gonzalez (25) and McCloskey 
and Mitchell (102) offered insights into the afferent arm of this reflex as they 
demonstrated the capacity of group III and IV ergoceptive fibers to elicit a reflex pressor 
response (i.e., increase in arterial blood pressure), while in addition they showed that 
the group I and II proprioceptive afferents played no role in evoking such a reflex.  
Further animal studies discovered multiple stimulus modalities for group III and IV 
afferents.  In general, group III afferents were shown to be primarily responsive to the 
mechanical stresses generated during muscle contraction (e.g., increases in tissue 
pressure) (63; 77; 78; 125), while group IV afferents were found to be acutely sensitive 
to metabolites (e.g., hydrogen ion, lactate, potassium ion, diprotonated phosphate and 
ATP) which accumulate within underperfused active skeletal muscle (34; 61; 86; 95; 
128; 145; 146; 157).  In support of these findings, the anatomical location of ergoceptive 
afferents has been visualized via electron microscopy revealing, in general, that group 
III afferent nerve endings are intimately associated with the connective tissue elements 
of skeletal muscle, whereas group IV afferent nerve endings emanate from small blood 
vessels within the muscle (160).  Adding a layer of complexity, many studies have 
demonstrated that “mechanoreceptors” can be sensitized by muscle metabolites 
developed during ischemia and that “metaboreceptors” are sensitive to mechanical 
stimulation (77; 85; 86; 127; 129).  Nonetheless, as a result of these findings, group III 
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and IV afferents were classified as mechanoreceptors and metaboreceptors, 
respectively.  It therefore became evident that the metabolically, chemo-sensitive reflex 
pressor response suggested by Alam and Smirk and other investigators, now referred to 
as the muscle metaboreflex, was indeed initiated by group III and group IV afferents. 
Muscle Metaboreflex: the Efferent Arm 
Following up on the early work elucidating the afferent structure and function of 
the muscle metaboreflex, a litany of experiments has been performed in humans and in 
animals with the intent of investigating its efferent arm.  Early investigators not only 
observed reflex-induced pressor responses, reflex increases in other hemodynamic 
(e.g., HR and pulmonary (e.g., ventilation) parameters were additionally reported in their 
studies (5; 11; 24; 102).  In order to study the efferent mechanisms of the muscle 
metaboreflex, focus was shifted to measuring and analyzing the hemodynamic 
outcomes of muscle metaboreflex-induced increases in sympathetic outflow from the 
CNS.  Incidentally, the mechanisms of integration in the control center of this reflex (i.e., 
the brainstem) are not well known.  A very common approach developed to elicit and 
study the reflex is the induction of skeletal muscle ischemia (by way of vascular 
occlusion) prior to or during a bout of static or dynamic  exercise (3; 4; 11; 24; 26; 31; 
74; 116; 144; 163).  Data from these types of experiments not only supported the 
findings of earlier studies, but also expanded the list of muscle metaboreflex-induced 
efferent responses.  Along with increases in mean arterial pressure (MAP), HR and 
cardiac output (CO), the muscle metaboreflex has additionally been shown to increase 
stroke volume (SV) (144), right atrial pressure (RAP) (140), ventricular performance (27; 
34; 116; 138; 151; 152) and sympathetic nerve activity (SNA) (114; 158; 159).  Even 
though there are innumerable observations of reflex-induced increases in these 
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cardiovascular parameters during exercise, most data suggest that the muscle 
metaboreflex only presents its negative feed-back influence over cardiovascular control 
when skeletal muscle is faced with a mismatch between oxygen supply and demand 
(i.e., during ischemia).  As muscle metabolites normally accumulate as a result of a 
decrease in perfusion to the working muscle, the muscle metaboreflex has often been 
regarded as a flow-sensitive reflex (120).  In fact, Wyss et al. (163) demonstrated the 
existence of a threshold for such a “flow error signal” while studying canines 
dynamically exercising at varying work intensities.  In general, as the intensity of the 
workload increased hindlimb perfusion progressively fell and the margin for error in 
muscle blood flow approached zero.  In contrast, data from Sheriff et al. (143) showed 
that it is not a reduction in flow per se that triggers the accumulation of muscle 
metabolites, rather it is a reduction in oxygen delivery to the muscle.  In any event, there 
is strong evidence that the muscle metaboreflex is tonically active during higher 
intensity (moderate to severe) exercise in dynamically exercising canines (14; 120; 
163).  Furthermore, in disease states where perfusion to skeletal muscle is impaired, 
such as in heart failure or peripheral arterial stenosis, the muscle metaboreflex may 
indeed be active even during lower intensity (mild to moderate) dynamic exercise (59; 
94).  It is generally believed that cardiovascular responses to mild exercise are 
controlled by feed-forward CNS efferent commands (i.e., central command) and 
principally modulated by the negative feed-back influence of the arterial baroreflex. 
However, there are data implicating muscle metaboreflex influence over cardiovascular 
function during mild exercise as well (2; 6; 135).  Very recently, Amann et al. (6) 
provided evidence in humans that increases in MAP, CO, HR and ventilatory rate during 
mild exercise might be, in part, controlled by a tonically active muscle metaboreflex.   
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Muscle Metaboreflex Activation During and Following the Cessation of Exercise  
In an attempt to separate the previously reported efferent responses of the 
muscle metaboreflex from the influence of central command and the baroreflex, 
investigators sought to “isolate” the reflex during the recovery from exercise.  This 
technique, first employed by Alam and Smirk, was designed to induce ischemia (by way 
of vascular occlusion) in the muscle immediately upon or before the cessation of the 
exercise and is commonly referred to as post-exercise muscle ischemia (PEMI) (16; 19; 
31; 45; 102; 132).  As expected, the cardiovascular parameters previously reported to 
be augmented by muscle metaboreflex activation during ischemic exercise are 
sustained during the recovery from exercise so long as the imposed circulatory 
occlusion is sustained, or PEMI (4; 19; 30; 45; 115; 133; 144).  Curiously though, there 
is one notable exception.  The vast majority of studies sustaining muscle metaboreflex 
activation during PEMI report a decline in HR during this maneuver while the pressor 
response is sustained (5; 16; 31; 45; 133; 144; 159).  With HR precipitously declining 
towards resting levels during PEMI, with a time-course similar to normal recovery from 
exercise, muscle metaboreflex control over the chronotropic function of the heart was 
drawn into question (46; 133; 134; 159).  Moreover, as CO is directly proportional to HR, 
questions immediately arose regarding the mechanism(s) sustaining the pressor 
response observed during PEMI in the absence of a sustained elevation in HR.  In the 
absence of a CO component, the only other mechanism available to sustain an 
elevation in MAP during PEMI would be peripheral vasoconstriction.  Indeed, previous 
studies both support (19; 30-32; 123; 132; 144) and refute (16; 32; 123) any role for CO 
in mediating the pressor response during PEMI.  Clearly, the role of CO vs. peripheral 
vasoconstriction in mediating the pressor response during PEMI is debatable, and it 
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remains a controversial issue yet to be resolved.  
In contrast to PEMI, it is well documented that during submaximal ischemic 
exercise, the pressor response occurs primarily via increased CO with little, if any, 
peripheral vasoconstriction (38; 59; 83; 116; 131; 140; 163).  Interestingly, many studies 
have demonstrated a “switch” from a flow-mediated rise in MAP during exercise to a 
vasoconstriction-mediated pressor response, when the reflex increase in CO is 
attenuated.  For example, Sheriff et al. (140) and Ichinose et al. (68) demonstrated 
substantial decreases in peripheral vascular conductance (i.e., increases in peripheral 
vasoconstriction) when they abolished the metaboreflex-induced increase in CO during 
mild, dynamic exercise via ventricular pacing with β1-adrenergic blockade or mechanical 
occlusion of the vena cavae, respectively.  In addition, Augustyniak et al. (14) 
demonstrated a shift from CO to peripheral vasoconstriction when workload approached 
maximal levels and further increases in CO were limited.  Moreover, studies from 
O’Leary and colleagues (59) and others (29) have demonstrated this same shift from 
CO to peripheral vasoconstriction in heart failure, a condition in which CO is attenuated 
as a result of impaired inotropic and/or chronotropic function.  Thus, it appears that 
whether or not increases in CO or peripheral vasoconstriction is utilized as a means to 
raise MAP with metaboreflex activation during dynamic exercise is dependent on the 
ability to increase CO.   
Very recently, Sala-Mercado et al. (136) reported attenuated metaboreflex-
induced chronotropic, inotropic and lusitropic responses in hypertension (HTN) during 
submaximal dynamic exercise.  Inasmuch as increases in CO with metaboreflex 
activation were markedly reduced, the rise in MAP was attenuated as well.  The pressor 
response likely resulted from a combination of the small increase in CO and enhanced 
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peripheral vasoconstriction.  Other studies investigating muscle metaboreflex function in 
HTN are limited, and the overall findings are equivocal: exaggerated (35; 52; 89; 106; 
107; 139; 148) vs. attenuated (126) metaboreflex responses.  Moreover, the 
mechanisms sustaining the muscle metaboreflex-mediated pressor response during 
PEMI in HTN are virtually unknown.   
Muscle Metaboreflex Activation and Ventricular Performance 
It is well known that CO is impaired in heart failure and that exercise in this 
condition results in muscle metaboreflex-mediated pressor responses that are 
principally generated by increases in peripheral vasoconstriction, not CO.  Hammond et 
al. (59) concluded that the observed peripheral vasoconstriction in heart failure was 
mediated by exaggerated SNA (as indexed by elevated plasma norepinephrine (NE) 
levels) and elevations in other vasoactive hormones such as arginine vasopressin 
(AVP) and renin.  Though one of the hallmarks of heart failure is heightened 
sympathoactivation at rest, this study additionally reported significant increases in SNA 
(and vasoactive hormones) with muscle metaboreflex activation during exercise.  The 
peripheral vasculature is not the sole efferent target of this reflex-induced elevation in 
SNA as there is marked sympathoactivation of the heart as well leading to increases in 
its chronotropic and inotropic functions as previously discussed.  Inasmuch as vascular 
smooth muscle cells of coronary blood vessels express alpha adrenergic receptors, 
they too are potential efferent targets of this elevated sympathetic outflow.  An increase 
in SNA to the heart can activate vascular smooth muscle α1-adrenergic receptors 
resulting in vasoconstriction of the coronary arteries (27; 57; 108).  On the other hand, 
an increase in SNA to the heart will also increase the work done by the heart which can 
in turn lead to the generation of local metabolites that induce a coronary vasodilation.  
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Another potential mechanism of coronary vasodilation is the feed-forward sympathetic 
activation of coronary β2-adrenergic receptors (49).  Overall, coronary vasomotor tone 
appears to be principally modulated by local metabolic vasodilation (i.e., active 
hyperemia) and sympathetically-mediated α1-adrenergic vasoconstriction (37; 40; 156).  
The balance of these antagonistic mechanisms will ultimately determine the degree of 
perfusion of the heart, or coronary blood flow (CBF).  At rest, the heart is an oxygen 
sink, as it extracts upwards of 80% of the oxygen in arterial blood (37; 40).  An increase 
in workload on the heart (e.g., the onset of exercise) increases myocardial oxygen 
demand, however this poses a significant challenge to the heart as it is incapable of 
extracting a significantly greater fraction of oxygen from the very blood it strips 80% 
from at rest.  Therefore, a coronary vasodilatory reserve is of paramount physiological 
importance to the heart, as an increase in CBF serves as the primary mechanism to 
increase the supply of oxygen available to the heart.  An increase in perfusion pressure 
to the heart will lead to an increase in oxygen delivery but will also initiate a myogenic 
autoregulatory vasoconstriction.  However, this negative feed-back mechanism is 
counteracted by a metabolic coronary vasodilation when the workload of the heart 
significantly increases (e.g., during moderate or severe exercise) permitting marked 
increases in CBF.  
There are reports, however, of an α1-adrenergic constrictor tone which reduces 
this coronary vasodilatory reserve during exercise.  Gwirtz et al. (57) demonstrated that 
as workload increases, there is progressively greater α1-adrenergic tone which restrains 
the metabolic coronary vasodilation.  Ansorge et al. (10) examined the potential 
contribution of the muscle metaboreflex to this α-adrenergic-mediated coronary 
vasoconstriction phenomenon by measuring CBF and coronary vascular conductance 
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(CVC) during dynamic exercise in canines.  During severe exercise, they reported an 
attenuated reflex increase in CBF along with a significant reduction in CVC due to 
accentuated coronary vasoconstriction with muscle metaboreflex activation.  They 
concluded that the muscle metaboreflex-induced rise in SNA to the heart functionally 
vasoconstricts the coronary vasculature, thereby attenuating the rise in CBF.  Thus, 
during strenuous exercise any coronary metabolic vasodilation induced by the increase 
in myocardial performance is counteracted by an increase in sympathetically-mediated 
coronary vasoconstriction.  These findings, along with the data demonstrating 
heightened SNA in canines with heart failure at rest and during exercise with muscle 
metaboreflex activation, suggested a possible mechanism for the impaired CO 
responses observed in heart failure.  Indeed, Ansorge et al. (9) demonstrated a 
significant reduction in CVC leading to an attenuated rise in CBF with muscle 
metaboreflex activation during mild and moderate exercise in animals with heart failure.  
They suggested that the marked coronary vasoconstriction observed in heart failure 
with muscle metaboreflex activation was as a potential mechanism responsible for the 
reduced ability to raise CO in this condition.  O’Leary et al. (118) reported another 
potential mechanism for this impaired CO response with muscle metaboreflex activation 
in heart failure during exercise when they demonstrated a concomitant reduction in SV.  
A reduced SV with muscle metaboreflex activation in heart failure suggested impaired 
ventricular function and/or preload and, in fact, subsequent studies from O’Leary and 
colleagues (137) reported impaired ventricular contractility with muscle metaboreflex 
activation in heart failure during exercise.  Furthermore, Gwirtz et al. (57) and O’Leary et 
al. (119) additionally reported an increase cardiac performance and CO, respectively, as 
a result of an abolition of coronary vasoconstriction following α-adrenergic blockade 
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during exercise.  Coutsos et al. recently demonstrated that during mild, dynamic 
exercise sympathetically-mediated restraint of coronary vasodilation (the extent 
determined by α-adrenergic blockade) during muscle metaboreflex activation impairs 
increases in left ventricular contractility in normal (27) and heart failure (28) animals.  
Collectively, these data suggest that a sympathetically-mediated restraint of metabolic 
coronary vasodilation during periods of increased myocardial metabolic demand can 
limit the rise in CBF and therefore further limit increases in ventricular performance and 
the rise in CO as seen in heart failure.  
As with heart failure, HTN is a condition in which individuals present with 
exaggerated levels of SNA (8; 51; 54; 72; 97; 101; 105; 155).  Moreover, resting 
coronary vasoconstriction and restrained coronary metabolic vasodilation during 
submaximal dynamic exercise (presumably due to heightened SNA) has been 
demonstrated in canines with renovascular HTN (55).  Sala-Mercado et al. (136) 
reported attenuated metaboreflex-induced increases in ventricular function and CO in 
HTN (Goldblatt 2K1C (47; 48)) during submaximal dynamic exercise.  The extent to 
which coronary vasoconstriction contributes to impaired ventricular function observed 
during muscle metaboreflex activation in HTN is unknown.   
Summary/Dissertation Aims  
Skeletal muscle ischemia during or immediately following exercise leads to the 
accumulation of metabolites (e.g., lactate and proton) which activate chemoreceptive 
afferents within the muscle leading to a reflex increase in sympathetic outflow 
generating substantial increases in MAP, CO and HR - termed the muscle 
metaboreflex.  The muscle metaboreflex is generally regarded as a flow-sensitive reflex 
that is elicited when skeletal muscle is faced with a mismatch between oxygen supply 
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and demand, and thereby increases cardiac function in an attempt to increase perfusion 
to the ischemic muscle.   
Two different approaches have been employed to study this reflex. Blood flow to 
the exercising muscle can be reduced prior to or during a bout of static or dynamic 
exercise thereby activating the reflex during ischemic exercise.  In contrast, the reflex 
can be elicited by inducing ischemia in the muscle immediately before or upon 
cessation of the exercise – PEMI.  When the reflex is activated during sustained 
submaximal dynamic exercise, the pressor response occurs primarily via increased CO.  
In contrast, during PEMI, whereas MAP remains elevated for as long as the ischemia is 
maintained, HR precipitously declines towards resting levels drawing into question the 
role of CO in mediating the pressor response during this period.  Indeed, the role of CO 
in mediating the pressor response during PEMI remains debatable.   
Specific Aim (I): To determine the mechanism(s) mediating the muscle-
metaboreflex-induced pressor response observed during PEMI in normal 
subjects.   
Many studies have demonstrated a “switch” from a flow-mediated rise in MAP 
during exercise to a vasoconstriction-mediated pressor response when the reflex 
increase in CO is attenuated (e.g., in heart failure).  It appears that whether or not 
increases in CO or peripheral vasoconstriction is utilized as a means to raise MAP with 
metaboreflex activation during dynamic exercise or sustain it during PEMI is dependent 
on the ability to increase CO.  In HTN, metaboreflex-mediated increases in CO are 
markedly attenuated during mild exercise.  
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Specific Aim (II): To determine the mechanism(s) mediating the muscle-
metaboreflex-induced pressor response observed during PEMI in hypertensive 
subjects.   
In heart failure, a sympathetically-mediated restraint of metabolic coronary 
vasodilation with metaboreflex activation during submaximal dynamic exercise limits the 
rise in CBF and therefore further limits increases in ventricular performance and the rise 
in CO.  In HTN, metaboreflex-mediated increases in ventricular function and CO are 
markedly attenuated during mild exercise.  As SNA is exaggerated in both heart failure 
and HTN, it is plausible that the mechanisms mediating the attenuation of CO in HTN 
with muscle metaboreflex activation are similar to those previously described in heart 
failure.   
Specific Aim (III): To determine if muscle metaboreflex activation during 
submaximal dynamic exercise in hypertensive animals induces a sympathetic 
restraint of metabolic coronary vasodilation that limits the rise in CBF and 
whether this restraint of CBF further limits increases in ventricular performance.   
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CHAPTER 2 
Role of Cardiac Output vs. Peripheral Vasoconstriction in Mediating Muscle 
Metaboreflex Pressor Responses:  Dynamic Exercise vs. Post-Exercise Muscle 
Ischemia 
Abstract 
Muscle metaboreflex activation (MMA) during submaximal dynamic exercise in 
normal individuals increases mean arterial pressure (MAP) via increases in cardiac 
output (CO) with little peripheral vasoconstriction.  The rise in CO occurs primarily via 
increases in heart rate (HR) with maintained or slightly increased stroke volume.  When 
the reflex is sustained during recovery (post-exercise muscle ischemia - PEMI), HR 
declines yet MAP remains elevated.  The role of CO in mediating the pressor response 
during PEMI is controversial.  In seven chronically instrumented canines, steady-state 
values with MMA during mild exercise (3.2 km/h) were observed by reducing hindlimb 
blood flow by ~60% for 3-5 minutes. MMA during exercise was followed by 60 s of 
PEMI.  Control experiments consisted of normal exercise and recovery.  MMA during 
exercise increased MAP, HR, and CO by 55.3 ± 4.9 mmHg, 42.5 ± 6.9 beats/min and 
2.5 ± 0.4 l/min, respectively.  During sustained MMA via PEMI, MAP remained elevated 
and CO remained well above the normal recovery levels.  Neither MMA during dynamic 
exercise nor during PEMI significantly affected peripheral vascular conductance.  We 
conclude that the sustained increase in MAP during PEMI is driven by a sustained 
increase in CO not peripheral vasoconstriction. 
Introduction 
Skeletal muscle ischemia during or immediately after exercise leads to the 
accumulation of metabolic by-products that activate group III and IV chemosensitive 
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afferents within the muscle (21; 34; 79; 86; 95; 128; 143; 145; 146; 157).  Activation of 
these skeletal muscle afferents causes a reflex increase in sympathetic outflow that 
generates substantial increases in arterial pressure termed the muscle metaboreflex (4; 
11; 24; 46; 102; 114-116; 121; 132; 133; 163).  Two different approaches have been 
employed to study this reflex.  Blood flow to the exercising muscle can be reduced 
before or during a bout of static or dynamic exercise thereby activating the reflex during 
ischemic exercise (3; 4; 11; 24; 26; 31; 116; 144; 163).  In contrast, the reflex can be 
elicited by inducing ischemia in the muscle immediately before or upon cessation of the 
exercise [a technique termed post-exercise muscle ischemia (PEMI)] (16; 19; 31; 45; 
46; 102; 132; 133; 157; 161).   
When the reflex is activated during sustained submaximal dynamic exercise in 
normal subjects, the pressor response occurs primarily via increased cardiac output 
(CO), which is driven by increased heart rate (HR) coupled with sustained or slightly 
increased stroke volume (SV) (31; 68; 138; 144; 163).  SV is maintained despite this 
tachycardia due to both enhanced ventricular contractility (27; 30; 116; 138) and 
maintained or increased ventricular filling pressure via substantial central blood volume 
mobilization (140).  In contrast, during PEMI, whereas mean arterial pressure (MAP) 
remains elevated for as long as the ischemia is maintained, HR precipitously declines 
toward resting levels with a time course similar to normal recovery, which led some to 
speculate that the muscle metaboreflex has little control over the heart (4; 45; 98; 133; 
158; 159; 161).  With HR on the decline during the recovery from exercise with or 
without PEMI, the role of CO in mediating the pressor response during PEMI remains 
controversial.  Indeed previous studies both support (19; 30-32; 123; 132; 144) and 
refute (16; 32; 123) any role for CO in mediating the pressor response during PEMI.  In 
15 
 
the present study, we elicited the muscle metaboreflex during dynamic exercise and 
sustained this activation during PEMI to compare the mechanisms underlying the 
muscle metaboreflex-mediated pressor responses in these two distinct settings. 
Methods 
Experimental subjects.  Seven adult mongrel canines were selected for the 
study.  All animals were healthy, ~20-25 kg body weight, of either sex (4 females; 3 
males), well adapted to the laboratory environment and willing to run on a motor-driven 
treadmill.  During experimentation, all animals exercised voluntarily and no negative 
reinforcement techniques were utilized.  The protocols developed and employed in the 
present study were reviewed and approved by the Institutional Animal Care and Use 
Committee of Wayne State University and complied with the National Institutes of 
Health Guide to the Care and Use of Laboratory Animals.   
Surgical procedures.  Each animal was completely instrumented with chronic, 
indwelling cardiovascular devices following two sterile surgical procedures: left 
thoracotomy and left flank retroperitoneal surgery in that order.  The animals recovered 
a minimum of 10 days before the second surgery and a minimum of 7 days before the 
first experiment.  During preoperative care, the animals were initially sedated with 
acepromazine (0.4-0.5 mg/kg IM).  After adequate sedation, the animals were 
anesthetized with a combined treatment of ketamine and diazepam (5.0 and 0.22 mg/kg 
IV, respectively).  Anesthesia was maintained with isoflurane gas (1-3%) after 
endotracheal intubation.  In addition, the animals received preoperative administration 
of cefazolin (antibiotic; 30 mg/kg IV), carprofen (analgesic; 4.0 mg/kg IV), buprenorphine 
(analgesic; 0.01 mg/kg IM) and fentanyl [analgesic; 125-175 µg/h, (72h) TDD].  Before 
the left thoracotomy, animals received selective intercostal nerve blockade with 
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bupivacaine HCl (2.0 mg/kg SQ).  After each surgical procedure, animals received 
cefazolin (30 mg/kg IV) and prophylactic cephalexin [antibiotic; 30 mg/kg (BID) PO] 
therapy for the term of the experimental protocol.  During the 12-hour post-operative 
period, animals were closely monitored and received buprenorphine and acepromazine 
(0.05 and 0.5 mg/kg IV, respectively) as needed.  For the following 10 days, animals 
received carprofen [4 mg/kg (OPD) PO].   
In the first surgical procedure, the thoracic cavity was opened via a left 
thoracotomy (4th intercostal space) approach.  The pericardium was cut and reflected to 
expose the heart.  An ultrasonic perivascular flow probe (20PAU, Transonic Systems) 
was positioned around the ascending aorta to measure CO.  Approximately 10 cm 
caudal to the thoracotomy incision, an implantable telemetry blood pressure transmitter 
(TA11 PA-D70, Data Sciences International) was tethered subcutaneously.  The 
catheter of the transmitter was tunneled into the thoracic cavity through the 7th 
intercostal space, and the tip was inserted and secured inside the left ventricle for 
measuring left ventricular pressure (LVP).  For studies unrelated to the present 
investigation a blood flow transducer was also placed on the left circumflex artery.  The 
pericardium was loosely re-approximated, the cables were tunneled subcutaneously 
and exteriorized between the scapulae and the chest was closed in layers.   
In the second surgical procedure, an incision was made in the left flank cranial to 
the iliac crest.  The abdominal aorta was exposed and an ultrasonic perivascular flow 
probe (10PAA, Transonic Systems) was positioned around the terminal aorta for 
measuring hindlimb blood flow (HLBF).  All arterial side branches between the common 
iliacs and the flow probe were ligated and severed.  In addition, two perivascular 
hydraulic occluders (8-10 mm, DocXS Biomedical Products) were positioned around the 
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terminal aorta (distal to the flow probe) to provide the means to incrementally reduce 
HLBF.  A 19-gauge polyvinyl catheter (S54-HL, Tygon, Norton) was advanced through a 
ligated lumbar artery and secured into the terminal aorta cranial to the probe and 
occluders to measure arterial pressure.  For studies unrelated to the current 
investigation a blood flow transducer and vascular occluder were placed on the left 
renal artery.  The cables and vascular occluder tubing were tunneled subcutaneously 
and exteriorized between the scapulae. 
Data acquisition.  After complete postoperative recovery, each animal was 
brought into the laboratory and allowed to roam freely and acclimate for ~15-20 min.  
The animal was then directed onto the treadmill where the instrumentation was 
connected to the data acquisition system (TS420, Transonic Systems Blood Flow 
Meter, Gould; amplifiers, Data Science International, Telemetry System, LabScribe, 
iWorx). 
Experimental procedures.  All animals performed both control and experimental 
procedures on separate days, therefore, each animal served as its own control.  The 
experiments began with the animal standing unrestrained on the treadmill until all 
hemodynamic data were observed to be stable (typically 5-10 min).  The treadmill was 
turned on and the speed was gradually increased to 3.2 km/h at 0% grade [a mild 
workload for a canine (60)].  Steady state was generally reached within 3-5 min.  In the 
control experiment, after all variables had reached steady state during exercise, the 
treadmill was abruptly stopped and post-exercise (without ischemia) hemodynamic data 
were collected for 60 s while the animal was standing still.  In a separate experiment, 
the muscle metaboreflex was engaged via partial reductions in HLBF during mild 
exercise.  Once the reflex was strongly engaged, steady-state data were collected for 
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60 s.  The treadmill was then abruptly stopped and the occlusion was sustained for an 
additional 60 s (PEMI). 
Data analysis.  CO, HLBF, LVP, HR and MAP data were continuously recorded 
during each experiment.  Other hemodynamic parameters were calculated off-line [e.g., 
SV, dP/dtmax, dP/dtmin and non-ischemic vascular conductance (NIVC)].  NIVC was 
calculated as (CO - HLBF)/MAP and reflects vascular conductance of all vascular beds 
except the hindlimbs.  Because of technical difficulties, we were only able to obtain 
LVPs from six animals.  One-minute averages of steady-state data were calculated at 
rest, during exercise and during metaboreflex activation.  5 s averages were computed 
for both 60 s post-exercise conditions: post-exercise (without ischemia) and PEMI.  
These mean values were then averaged across all animals to obtain the mean values 
for the entire population of the study.  Finally, the last 10 s of recovery were averaged. 
Statistical analysis.  Averaged responses for each animal were analyzed via two-
way repeated measures ANOVA to compare hemodynamic data for time and/or 
condition effects.  In the event of a significant time-condition interaction, a C-matrix test 
for simple effects was performed.  Data are reported as means ± SE, and statistical 
significance was ascribed as P < 0.05. 
Results  
Figure 2.1 shows the responses in MAP, CO, HR, SV and HLBF from a control 
and experimental protocol in one animal.  In both protocols, with the transition from rest 
to exercise, there was a minimal increase in MAP and modest increases in CO and HR 
concomitant with a substantial rise in HLBF.  During the normal recovery from exercise, 
MAP remained unchanged while CO and HR gradually fell toward resting levels.  In the 
experimental protocol, the muscle metaboreflex was elicited immediately following 
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steady-state exercise and sustained during the post-exercise recovery period (PEMI).  
Muscle metaboreflex activation during the experimental protocol led to marked 
increases in MAP, CO and HR and little change in SV.  During PEMI, the rise in MAP 
was sustained.  Although CO and HR initially fell during the onset of PEMI, both 
subsequently plateaued well above their normal recovery levels.   
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Figure 2.2 shows the average values 
of MAP, HR, CO and NIVC during control 
and experimental procedures.  The 60 s of 
post-exercise recovery are plotted as 5 s 
averages.  The changes in MAP, HR, CO 
and NIVC from rest to exercise were not 
significantly different between the control and 
experimental protocols.  With muscle 
metaboreflex activation during exercise, 
MAP, HR and CO increased substantially.   
 
 
 
 
 
 
 
During PEMI, the ~60 mmHg rise in MAP, which was observed with muscle 
metaboreflex activation, was sustained during the entire 60 s, as every data point during 
this maneuver was significantly different from control.  NIVC fell during the PEMI period 
Figure 2.2.  Averaged time-course of 
MAP, HR, CO and non-ischemic vascular 
conductance (NIVC) during control (open 
circles) and experimental procedures (filled 
circles) in 7 animals.  Data at rest are the 
average values from both settings (half-
filled circles). * - p<0.05. 
21 
 
with a pattern not significantly different from during the normal recovery from exercise.  
HR and CO decreased abruptly during the first 15 s of PEMI; however, both of these 
variables subsequently plateaued significantly above normal recovery levels.   
Figure 2.3 shows the mean hemodynamic responses during exercise and the 
final 10 s of recovery with and without muscle metaboreflex activation.  During the last 
10 s of ischemic exercise, there were significant increases in MAP, CO, HR, dP/dtmax 
and dP/dtmin compared with the data during exercise without metaboreflex activation.   
 
 
Figure 2.3.  Mean hemodynamic responses during exercise and the final 10 
seconds of recovery with (filled bars) and without (open bars) muscle metaboreflex 
activation.  * - p<0.05 between normal exercise and ischemic exercise, † - p<0.05 
between normal recovery from exercise (open bars) and post-exercise muscle 
ischemia (PEMI) (filled bars). 
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During the last 10 s of the recovery from ischemic exercise, MAP, CO, HR, 
dP/dtmax and dP/dtmin were all significantly elevated compared with the values during the 
normal recovery from exercise, whereas there were no significant changes in NIVC or 
SV. 
Discussion 
Our major finding is that the mechanisms mediating muscle metaboreflex-
induced increases in arterial pressure are similar both when the reflex is activated 
during dynamic exercise and when the reflex is sustained during the recovery from 
exercise.  In both settings, the pressor response is primarily due to a substantial 
elevation in CO with little, if any, peripheral vasoconstriction.  Moreover, the elevation in 
CO is driven via an increased HR with a sustained SV.  Inasmuch as tachycardia itself 
can lead to decreases in SV (87; 162), increases in ventricular contractility likely 
contribute to the sustained SV.  The elevated dP/dtmax supports this conclusion.  Faster 
left ventricular relaxation (dP/dtmin) may also aid in the maintenance of SV by increasing 
filling time.  Therefore, our data demonstrate marked muscle metaboreflex-induced 
chronotropic, inotropic and lusitropic responses both when the reflex is activated during 
dynamic exercise and when the reflex is sustained during recovery from exercise. 
Muscle metaboreflex activation during exercise. CO versus vasoconstriction.  
Muscle metaboreflex activation during exercise evokes large increases in MAP, HR and 
CO (4; 5; 39; 104; 115; 116; 163).  However, the relative roles of CO versus peripheral 
vasoconstriction in this pressor response have been unclear.  We observed a 45% 
increase in CO with muscle metaboreflex activation during exercise with no significant 
peripheral vasoconstriction.  We determined the extent of peripheral vasoconstriction by 
calculating the conductance of all vascular beds with the exception of the hindlimbs 
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(NIVC) (13). Changes in hindlimb conductance must be excluded due to the mechanical 
effects of the occlusion.   
Previous studies have demonstrated a “switch” in the mechanisms of the muscle 
metaboreflex from a flow-mediated rise in MAP to a vasoconstriction-mediated pressor 
response when the reflex increase in CO is attenuated.  For example, Sheriff et al. (140) 
and Ichinose et al. (68) demonstrated substantial peripheral vasoconstriction when the 
metaboreflex-induced increase in CO was either pharmacologically or mechanically 
prevented.  In addition, Augustyniak et al. (14) demonstrated a shift from CO to 
peripheral vasoconstriction when workload approached maximal levels and further 
increases in CO were limited.  Similar results have been observed in subjects with 
congestive heart failure, a setting where substantial increases in CO are limited (12; 29; 
59; 121).  Thus whether or not increased CO or increased vasoconstriction is utilized as 
a means to raise MAP with metaboreflex activation during dynamic exercise appears 
dependent on the ability to increase CO. 
Muscle metaboreflex activation during PEMI. CO versus vasoconstriction.  
Previous studies have come to markedly different conclusions regarding the relative 
roles of CO versus peripheral vasoconstriction in mediating the pressor response during 
PEMI [(19; 30-32; 123; 132; 144) versus (16; 32; 123)].  One potential explanation is 
that a CO response is often seen during imposed PEMI following more intense exercise, 
whereas PEMI following relatively lower exercise intensities tends to demonstrate little 
change in CO and the pressor response occurs via peripheral vasoconstriction.  We 
observed a maintained elevation in CO (~50% above the normal recovery level) during 
PEMI with little or no change in NIVC.  The time course of the recovery of NIVC during 
PEMI and the normal recovery from exercise are virtually indistinguishable and not 
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significantly different.  It should be noted that NIVC contains not only conductance to 
inactive areas, but a substantial amount of NIVC is skeletal muscle outside of the 
hindlimbs (58), which also vasodilates in response to the exercise.  Thus with exercise 
NIVC increases and during recovery NIVC falls.  To what extent this fall in NIVC during 
recovery with or without PEMI is neurogenic versus passive vasoconstriction due to 
reduced metabolic vasodilation in skeletal muscle is not known.  Previously, Sheriff et 
al. (141) has shown that after ganglionic blockade, skeletal muscle vasodilation during 
exercise markedly exceeds normal levels.  Regardless of whether or not tonic 
sympathetic activity controls the speed of recovery of NIVC, it is clear that the pattern of 
change in NIVC was not different between the normal recovery and during PEMI. 
Role of HR and SV in mediating metaboreflex-induced increases in CO during 
exercise versus PEMI.  Previous studies in dogs and humans have concluded that HR 
and CO increase markedly when the muscle metaboreflex is activated during exercise 
(12-14; 27; 29-31; 38; 59; 68; 116; 163); however, during PEMI the effects on HR are 
more variable.  In general, PEMI elicited from the arm following moderate exercise 
evokes little sustained tachycardia and any CO response occurs via increased SV (5; 
45; 123).  In contrast, if PEMI follows leg exercise, HR remains above normal recovery 
values, and therefore the relative tachycardia contributes to an elevated CO (5; 45; 
123).  The observations in humans following leg exercise are similar to those we 
observed in the present study using canines.  Collectively, these studies indicate that 
either the HR response during PEMI depends on which limb is used or that these 
differential responses are due to differences in muscle mass. 
Previous studies from our laboratory and others have concluded that during 
PEMI there are sustained increases in sympathetic tone to the heart; however, there are 
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concurrent increases in parasympathetic activity as well (69; 111; 114).  This combined 
activation of both arms of the autonomic nervous system causes bradycardia but 
sustained increased ventricular contractility (Figure 2.3).  The differences in the HR 
responses between PEMI and metaboreflex activation during dynamic exercise may 
reflect that during PEMI one is observing responses during the recovery from exercise 
rather than during exercise per se.  Muscle metaboreflex-induced tachycardia occurs 
primarily via increased sympathetic activity to the heart (44; 114).  With the cessation of 
exercise, parasympathetic activity rises abruptly, which masks the chronotropic effects 
of sustained sympathetic tone (note that the inotropic effect is well sustained during 
PEMI; (Figure 2.3).  The extent to which sympathetic nerve activity remains elevated 
during PEMI may be dependent on the intensity and type of exercise performed (e.g., 
isometric vs. isotonic).  For example, in canines, the muscle metaboreflex is not 
tonically active during mild, free-flow treadmill exercise but becomes tonically active as 
workload increases and/or ventricular function declines (14; 60; 163).  In addition, 
Fisher et al. (44) demonstrated in humans performing static handgrip exercise that 
“robust” muscle metaboreflex activation (achieved during high-intensity exercise) was 
required to sustain sympathetic nerve activity during PEMI to a degree such that the 
prevailing parasympathetic effects on HR were counteracted.  However, Amann et al. 
(7) recently concluded that skeletal muscle afferents contribute to the cardiorespiratory 
responses during relatively mild exercise in humans. 
The increases in CO with metaboreflex activation likely require increased 
contractility as well as central blood volume mobilization to raise or maintain SV with the 
elevated afterload and shortened ventricular filling time.  Previous studies from our 
laboratory showed that the muscle metaboreflex can elicit marked increases in central 
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blood volume mobilization (140) as well as ventricular contractility [as evidenced by 
increased left ventricular maximal elastance, preload recruitable stroke work, as well as 
dP/dtmax (27; 116; 138)].  Moreover, Little et al. (92; 93) have shown that increases in 
left ventricular end-diastolic volume per se can lead to increases in dP/dtmax.  Thus it is 
possible that a portion of the rise in contractility with metaboreflex activation may be 
directly attributable to enhanced central blood volume mobilization.   
In the present study, the increase in contractility was sustained during PEMI 
(Figure 2.3).  Shoemaker et al. (144) showed a substantial muscle metaboreflex-
induced increase in SV during ischemic exercise, and Crisafulli et al. (30) also reported 
an increase in SV and ventricular contractility with muscle metaboreflex activation 
during PEMI.  These reflex increases in SV were suggested by these authors to be the 
principal mechanisms behind the increase in CO in these two distinct settings as HR 
was not affected.  We did not observe a significant increase in SV with muscle 
metaboreflex activation during exercise or PEMI in our studies, and it is possible that 
these different results are species dependent.  For example, there are reports that 
canines have a limited end-diastolic reserve compared to humans (17).  In contrast, 
other studies have shown that canines possess significant preload reserve (90; 96).  
Nonetheless, a maintenance or increase in SV during a hemodynamic period in which 
ventricular filling time is markedly reduced can likely only be achieved if there is an 
increase in the contractile state and/or an increase in preload. 
Perspectives and Significance.  Activation of the muscle metaboreflex both 
during submaximal exercise and during the recovery from exercise elicits substantial 
increases in ventricular function.  The major mechanism of the muscle metaboreflex-
mediated pressor response is increased CO with little, if any, peripheral 
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vasoconstriction in both settings.  Inasmuch as when workload rises, an increasingly 
smaller fraction of CO is directed to non-active vascular beds (e.g., brain, kidneys and 
splanchnic organs), even complete vasoconstriction of these beds would cause only a 
limited increase in arterial pressure (113).  In contrast, a metaboreflex-mediated rise in 
CO generates substantial increases in arterial pressure.  Thus, in these settings, the 
muscle metaboreflex is a flow-raising, pressure-raising reflex.  The rise in total systemic 
blood flow increases systemic perfusion pressure which likely acts to partially restore 
blood flow to ischemic muscle (120). 
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CHAPTER 3 
Mechanisms Mediating the Muscle Metaboreflex Pressor Response during Post-
Exercise Muscle Ischemia are altered in Hypertension 
Abstract 
During dynamic exercise, muscle metaboreflex activation (MMA; induced via 
partial hindlimb ischemia) markedly increases mean arterial pressure (MAP) and MAP is 
sustained when the ischemia is maintained following the cessation of exercise (post-
exercise muscle ischemia – PEMI).  We previously reported that the sustained pressor 
response during PEMI in normal individuals is driven by a sustained increase in cardiac 
output (CO) with no peripheral vasoconstriction.  However, we have recently shown that 
the rise in CO with MMA is significantly blunted in hypertension (HTN).  The 
mechanism(s) sustaining the pressor response during PEMI in HTN are virtually 
unknown.  In six chronically instrumented canines, hemodynamic responses were 
observed during rest, mild exercise (3.2 km/h), MMA and PEMI in the same animals 
before and after the induction of HTN (Goldblatt 2K1C).  In control, MAP, CO and HR 
increased with MMA (+52 ± 6 mmHg, +2.1 ± 0.3 l/min and +37 ± 7 bpm).  After the 
induction of HTN, MAP at rest increased from 97 ± 3 to 130 ± 4 mmHg, and the 
metaboreflex responses were markedly attenuated (+32 ± 5 mmHg, +0.6 ± 0.2 l/min 
and +11 ± 3 bpm).  During PEMI in HTN, HR and CO were not sustained and MAP fell 
to normal recovery levels.  We conclude that the attenuated metaboreflex-induced HR, 
CO and MAP responses are not sustained during PEMI in HTN. 
Introduction 
The muscle metaboreflex is a very powerful blood pressure-raising reflex (4; 11; 
24; 46; 116; 132; 136; 163).  Metabolically-sensitive afferents of this reflex (group III/IV) 
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are stimulated by metabolites (e.g., protons, lactate, potassium and diprotonated 
phosphate) which accumulate within underperfused active skeletal muscle (21; 34; 79; 
86; 95; 128; 130; 145-147; 157).  Activation of the muscle metaboreflex results in a 
reflex increase in sympathetic outflow from the brainstem (20; 71; 75; 79; 98-100; 158).  
During submaximal dynamic exercise, metaboreflex activation markedly increases heart 
rate (HR), cardiac output (CO) and ventricular contractility (dP/dtmax) with no net effect 
on the peripheral vasculature (14; 30; 31; 59; 68; 144; 150; 163).  Therefore, the 
substantial metaboreflex-mediated pressor response observed during mild dynamic 
exercise is virtually solely the result of the increase in CO.  
In contrast, when metaboreflex activation is maintained following the cessation of 
submaximal dynamic exercise (post-exercise muscle ischemia - PEMI) in normal 
subjects, the pressor response is sustained despite several investigators reporting that 
HR falls towards resting levels (4; 5; 45; 123; 133; 134; 158; 159; 161).  The fall of HR 
during PEMI led many investigators to question the role of CO in mediating the 
sustained pressor response during PEMI (45; 133; 134; 159).  We recently 
demonstrated that the sustained pressor response during PEMI following submaximal 
dynamic exercise is principally driven by elevated CO, not peripheral vasoconstriction 
(150).  The sustained elevation in CO during PEMI is driven by enhanced chronotropy 
(5; 31; 43; 67; 114; 138; 163) coupled with a sustained or slightly elevated stoke volume 
(SV) (27; 31; 116; 138; 144; 150) which is supported by enhanced inotropy (dP/dtmax) 
(27; 30; 68; 116; 138; 150), lusitropy (dP/dtmin) (68; 150) and central blood volume 
mobilization (140).  Therefore, the mechanisms mediating muscle metaboreflex-induced 
increases in MAP are similar regardless of whether the reflex is activated during 
dynamic exercise or if it is sustained during the recovery from exercise (150). 
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Very recently, we reported attenuated metaboreflex-induced chronotropic, 
inotropic and lusitropic responses in hypertension (HTN) during submaximal dynamic 
exercise (136).  Several studies from our group (12; 14; 59; 68; 121; 140) and others 
(29) have demonstrated a “switch” from a flow-mediated to a vasoconstriction-mediated 
pressor response during exercise when the reflex increase in CO is artificially 
attenuated (68; 140) or when there is a physiological inability to increase CO, such as 
during severe exercise (14) or in heart failure (12; 29; 59; 121).  Thus, it appears that 
whether or not increases in CO or peripheral vasoconstriction is utilized as a means to 
raise MAP with metaboreflex activation during dynamic exercise is dependent on the 
ability to increase CO.   
The mechanisms sustaining the pressor response during PEMI in HTN are 
virtually unknown.  Inasmuch as metaboreflex-induced increases in HR, CO and 
dP/dtmax are markedly attenuated in HTN, we tested the hypothesis that the sustained 
pressor response during PEMI would be principally supported by increased peripheral 
vasoconstriction, not CO. 
Methods 
Experimental subjects.  Six adult female mongrel canines were selected for the 
study.  All animals were healthy, ~20-25 kg body weight, well adapted to the laboratory 
environment and willing to run on a motor-driven treadmill.  During experimentation, all 
animals exercised voluntarily and no negative reinforcement techniques were utilized.  
The protocols developed and employed in the present study were reviewed and 
approved by the Institutional Animal Care and Use Committee of Wayne State 
University and complied with the National Institutes of Health Guide to the Care and 
Use of Laboratory Animals.  
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Surgical procedures.  The animals were prepared as described previously (136).  
Briefly, in the first sterile surgical procedure (left thoracotomy), an ultrasonic 
perivascular flow probe was positioned around the ascending aorta to measure CO and 
the catheter of an implantable telemetry blood pressure transmitter was inserted and 
secured into the left ventricle to measure left ventricular pressure (LVP).  In the second 
surgical procedure, ultrasonic perivascular flow probes were placed around the terminal 
aorta and left renal artery for measuring hindlimb blood flow (HLBF) and renal blood 
flow (RBF), respectively.  Two perivascular hydraulic occluders were positioned around 
the terminal aorta (distal to the flow probe) to provide the means to incrementally reduce 
HLBF in order to engage the muscle metaboreflex.  One perivascular hydraulic occluder 
was positioned around the left renal artery (distal to the flow probe) in order to reduce 
RBF to induce HTN (2K1C Goldblatt model).  Lastly, a catheter was secured into the 
terminal aorta (cranial to the flow probe and occluders) to measure arterial pressure. 
Following both surgical procedures, buprenorphine (0.05 mg/kg IV) and 
acepromazine (0.5 mg/kg IM) were administered for analgesia and sedation, 
respectively.  The animals were treated with cefazolin (30 mg/kg IV) pre- and 
postoperatively and with cephalexin (30mg/kg PO, twice daily) prophylactically for the 
term of the experimental protocol.  The animals were allowed a minimum of ten days for 
recovery between surgical procedures and a minimum of seven days before running 
control experiments. 
Data acquisition.  After complete postoperative recovery, each animal was 
brought into the laboratory and allowed to roam freely and acclimate for approximately 
15-20 minutes.  The animal was then directed onto the treadmill where the 
instrumentation was connected to the data acquisition system.  CO, CBF, HLBF and 
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RBF flow probe cables were connected to transit-time perivascular flow meters (TS420, 
Transonic Systems).  The LVP telemetry signal was collected by a receiver connected 
to a calibrated analog adapter and a barometric pressure reference device (RMC-1, 
R11CPA, APR-1, respectively; DSI).  The arterial catheter was connected to a pressure 
transducer (Transpac IV, ICU Medical).  All aforementioned hemodynamic variables, in 
addition to MAP (calculated) and HR (triggered by the CO signal), were monitored as 
beat-by-beat averages and real-time waveforms by a data acquisition system 
(LabScribe, iWorx) and recorded for subsequent off-line analysis.  
Induction of hypertension.  After completion of control experiments, HTN was 
induced via a Goldblatt 2K1C model (47; 48).  Blood flow to the left kidney was reduced 
to a target level of ~30% of baseline via partial inflation of the renal vascular occluder.  
HTN gradually developed over the next several weeks.  We defined HTN as systolic 
pressure ≥140 mmHg and diastolic pressure ≥90 mmHg.  The experiments were 
repeated after 31.5 ± 3.4 days of sustained HTN. 
Experimental design.  Each animal performed two experimental protocols before 
(normal) and after induction of HTN, and therefore each animal served as its own 
control.  On each day, the experimental protocol sequence was randomized to avoid 
any order effect.  All experiments began with the animal standing unrestrained on the 
treadmill until all hemodynamic resting data were observed to be stable (~5-10 min).  
The treadmill was turned on and the speed was gradually increased to 3.2 km/h at 0% 
grade (mild exercise for a canine).  Steady-state exercise was generally reached within 
3-5 minutes.  The following is the design of the two experimental protocols: 
 
1) Free-flow Exercise and Post-exercise Recovery:  Following the 3.2 km/h steady-
state, the treadmill was abruptly stopped and post-exercise recovery (without 
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ischemia – i.e., free-flow) hemodynamic data were collected for 60 seconds while 
the animal was standing still.  
 
2) Muscle Metaboreflex Activation and Post-exercise Muscle Ischemia:  Following the 
3.2 km/h steady-state, the metaboreflex was engaged during the exercise via partial 
reductions in HLBF and steady-state data were collected for 60 seconds.  The 
treadmill was then abruptly stopped and the occlusion was sustained for an 
additional 60 seconds while the animal was standing still.   
 
Data analysis.  CO, HLBF, LVP, HR and MAP data were continuously recorded 
during each experiment.  Other hemodynamic parameters were calculated off-line (e.g., 
SV, non-ischemic vascular conductance (NIVC), total peripheral resistance (TPR), 
dP/dtmax and dP/dtmin).  Due to technical difficulties, we were only able to obtain dP/dtmax 
and dP/dtmin data for five animals.  One minute averages of steady-state data were 
calculated at rest, during exercise and during metaboreflex activation.  5 second 
averages were computed for the 60 seconds of post-exercise recovery and PEMI.  
Responses for these two settings were taken as the last averaged 10 seconds.  Mean 
values were averaged across all animals to obtain mean values for the entire population 
of the study. 
Statistical analysis.  Averaged responses for each animal were analyzed via two-
way repeated measures ANOVA to compare hemodynamic data for time and/or 
condition effects.  In the event of a significant time-condition interaction, a C-matrix test 
for simple effects was performed.  Data are reported as means ± SE and statistical 
significance was ascribed as p<0.05.  
Results  
Following induction of HTN, MAP was significantly elevated at rest which was 
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due to an increase in TPR (Table 3.1).  
Table 3.1. MAP, CO and TPR (mmHg, l/min and mmHg/l/min ± SE, respectively) during 
rest, exercise (EX), muscle metaboreflex activation (MMA) and the last 10 s of post-
exercise muscle ischemia (PEMI) before (normal) and after induction of hypertension. 
 
 
 
    
 
 
REST  96.9 ± 2.9  3.45 ± 0.20  28.7 ± 2.2 129.5 ± 3.7* 3.56 ± 0.26 37.4 ± 3.1* 
EX 101.8 ± 3.6 4.91 ± 0.32 21.4 ± 2.0  124.8 ± 4.4* 4.92 ± 0.25 25.8 ± 1.8* 
MMA 153.5 ± 4.9 7.03 ± 0.60 22.6 ± 2.0 156.7 ± 6.5 5.49 ± 0.36*  29.0 ± 1.8* 
PEMI 151.5 ± 5.0 5.19 ± 0.49 28.5 ± 2.1 142.6 ± 6.8 4.08 ± 0.38* 36.0 ± 2.6* 
* - p<0.05 normal vs. hypertension  
 
Figure 3.1 shows responses in MAP, CO, HR, SV and HLBF from one animal 
during rest,  mild  dynamic  exercise,  muscle metaboreflex activation and  PEMI  before 
 
(normal) and after induction of HTN.  Resting MAP was markedly elevated following 
induction of HTN while CO, HR, SV and HLBF were similar to the levels observed prior 
MAP MAPTPR TPRCOCO 
Normal Hypertension 
Figure 3.1. Time-course of 
mean arterial pressure 
(MAP), cardiac output (CO), 
heart rate (HR), stroke 
volume (SV) and hindlimb 
blood flow (HLBF) during 
rest, mild exercise, muscle 
metaboreflex activation 
(MMA) AND PEMI before 
(normal) (dotted black lines)
and after induction of 
hypertension (solid black 
lines) in one animal. Data 
represented are the final 60 s 
of steady-state data during 
rest, exercise and MMA. 60 s 
of PEMI immediately followed 
the MMA steady-state.
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to induction of HTN.  From rest to exercise, CO, HR and HLBF markedly increased 
while MAP and SV remained similar to the values observed at rest.  These 
cardiovascular responses were similar following induction of HTN.  MAP, CO, HR and 
SV significantly increased with muscle metaboreflex activation, however these 
responses were attenuated following 
induction of HTN.  During PEMI, MAP, CO 
and HR were sustained in control, but fell to 
normal recovery levels following induction of 
HTN.  
Figure 3.2 shows average values of 
MAP, HR, CO, and NIVC during rest, mild 
exercise, muscle metaboreflex activation 
and PEMI before and after induction of HTN.  
The 60 seconds of PEMI are plotted as 5 
second averages.  Following induction of 
HTN, MAP was significantly higher, HR and 
CO were unchanged and NIVC was 
significantly lower at rest and during mild 
exercise with respect to normal.  HLBF was 
M
ea
n 
A
rt
er
ia
l P
re
ss
ur
e 
(m
m
Hg
)
80
100
120
140
160
180
* *
C
ar
di
ac
 O
ut
pu
t 
(l/
m
in
)
2
4
6
8 *
*
*******
*
* **
He
ar
t R
at
e 
(b
ea
ts
/m
in
)
80
100
120
140
160
*
* * *
*
* *
*
* *
*
*
*
Time (s)
Re
st Ex
Me
tab
o 5 10 15 20 25 30 35 40 45 50 55 60
Va
sc
ul
ar
 C
on
du
ct
an
ce
 (m
l/m
in
/m
m
Hg
)
20
30
40
50
*
*
*
* *
* * * *
* *
* * *
*
Post-exercise Muscle Ischemia
Figure 3.2. Averaged time-course MAP, HR,
CO and non-ischemic vascular conductance
(NIVC) responses during rest, exercise, MMA
(Metabo) and 60 s of PEMI before (open
circles) and after induction of HTN (filled
circles). * - p<0.05 between normal and HTN.
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reduced to the same level to induce muscle metaboreflex activation and was similarly 
maintained during PEMI before and after induction of HTN.  Metaboreflex-induced 
increases in MAP, HR, CO and NIVC were markedly attenuated following induction of 
HTN.  During PEMI, HR, CO and NIVC were significantly lower than normal during the 
entire 60 seconds of PEMI following induction of HTN, while MAP was not any different. 
Figure 3.3 shows mean hemodynamic responses in MAP, NIVC, CO, HR, SV, 
dP/dtmax and dP/dtmin during rest, mild exercise and the final averaged 10 seconds of 
post-exercise recovery before and after induction of HTN.  Resting MAP and dP/dtmax 
were  significantly  elevated,  NIVC  significantly  reduced and  CO, HR, SV and dP/dtmin  
 
Figure 3.3. Mean hemodynamic responses in MAP, NIVC, CO, HR, SV, dP/dtmax and
dP/dtmin during rest, mild exercise (EX) and post-exercise recovery (POST-EX) before
(open bars) and after induction of HTN (filled bars). * - p<0.05 between normal and HTN;
† - p <0.05 from previous setting 
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were similar to normal following induction of HTN.  NIVC, CO, HR and dP/dtmax 
significantly increased from rest to mild exercise while MAP, SV and dP/dtmin were 
unchanged.  Following induction of HTN, NIVC were reduced during exercise, CO and 
HR significantly increased as in normal, while MAP, SV and dP/dtmax and dP/dtmin were 
similar to rest.  During the final averaged 10 seconds of post-exercise recovery, MAP, 
SV and dP/dtmin remained unchanged while NIVC, CO, HR and dP/dtmax fell to levels not 
significantly different from those observed at rest (p>0.05).  Following induction of HTN, 
MAP, SV and dP/dtmin remained unchanged while CO and HR fell to rest as in normal.  
NIVC was significantly reduced and dP/dtmax significantly elevated with respect to 
normal and both parameters fell to rest (p>0.05; rest vs. post-exercise recovery).  
Figure 3.4 shows mean hemodynamic responses in MAP, NIVC, CO, HR, SV, 
dP/dtmax and dP/dtmin during rest, mild exercise, muscle metaboreflex activation and the 
final averaged 10 seconds of PEMI before and after induction of HTN.  All 
hemodynamic responses at rest and during mild exercise before and after induction of 
HTN were similar as shown in Figure 3.3.  All cardiovascular parameters significantly 
increased with muscle metaboreflex activation, however following induction of HTN 
metaboreflex-induced increase in these parameters were markedly attenuated.  During 
the final averaged 10 seconds of PEMI, all parameters fell significantly below 
metaboreflex activation levels and, with the exception of NIVC, all remained significantly 
elevated above post-exercise recovery levels.  Following induction of HTN, SV, dP/dtmax 
and dP/dtmin remained at metaboreflex activation levels while MAP, NIVC, CO and HR 
fell to levels not significantly different from those observed during post-exercise 
recovery without PEMI. 
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Discussion 
Our major new findings are that the attenuated muscle metaboreflex-induced 
pressor response in HTN is not sustained during PEMI and the mechanisms sustaining 
the pressor response during PEMI in normal subjects are altered in HTN.  
Muscle metaboreflex activation during exercise in normal subjects elicits a 
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Figure 3.4. Mean hemodynamic responses in MAP, NIVC, CO, HR, SV, dP/dtmax and
dP/dtmin during rest, mild exercise (EX), MMA and PEMI before (open bars) and after
induction of HTN (filled bars). * - p<0.05 between normal and HTN; † - p <0.05 from
previous setting; # - p<0.05 between POST-EX and PEMI. 
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substantial pressor response which is sustained during PEMI (4; 16; 19; 30-32; 45; 46; 
102; 123; 132; 144; 157; 161).  We recently demonstrated that this sustained pressor 
response during PEMI is supported by a sustained increase in CO and not peripheral 
vasoconstriction (150).  The sustained CO during PEMI was driven by enhanced 
chronotropy coupled with a sustained SV which was supported by enhanced inotropy 
and lusitropy.  We further concluded that the mechanisms mediating metaboreflex-
induced pressor responses are similar both when the reflex is activated during dynamic 
exercise and when the reflex is sustained during the recovery from exercise (PEMI).  
Several studies have demonstrated a “switch” from a flow-mediated to a 
vasoconstriction-mediated pressor response during exercise when the reflex increase in 
CO is attenuated (14; 29; 59; 68; 140).  In the present study we observed substantially 
attenuated metaboreflex-induced CO and MAP responses in HTN as recently shown by 
Sala-Mercado et al. (136).  However, the pressor response during PEMI was not 
sustained via enhanced peripheral vasoconstriction.  During PEMI, CO, HR, dP/dtmax 
and dP/dtmin fell to normal recovery levels and, despite a downward baseline shift in 
NIVC during all settings, the recovery pattern of NIVC was similar to control indicating 
no increase in peripheral vasoconstriction.  Therefore, the attenuated pressor response 
was not sustained during PEMI in HTN.  
Few studies have investigated muscle metaboreflex function during PEMI in HTN 
and the findings are equivocal.  Farquhar and colleagues recently demonstrated in 
elderly hypertensive humans that the pressor response to static handgrip exercise (30-
40% MVC) is exaggerated in HTN and sustained during PEMI (35; 52).  However, in a 
previous study from this group with similar subjects (139), the pressor response to 
rhythmic handgrip exercise (60% MVC) was not exaggerated in HTN, yet MAP was 
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sustained during PEMI.  In contrast, Rondon et al. (126) did not find an exaggerated 
pressor response to static handgrip exercise (30% MVC) in humans with untreated HTN 
and blood pressure fell to baseline during PEMI.  While the lack of a sustained pressor 
response during PEMI in the hypertensive groups is in agreement with the present 
study, the absence of a sustained pressor response during PEMI in the normotensive 
group is perplexing.  The lack of congruency of the present and aforementioned studies 
may be due to several confounding factors including: differences in species, age, type 
and intensity of exercise performed and experimental methodology.  We discussed 
several of these issues in a previous study (150).   
Studies from Farquhar and colleagues have reported sustained elevations in 
muscle sympathetic nerve activity (MSNA) during PEMI in HTN indicating enhanced 
peripheral vasoconstriction (35; 52).  However, as CO was not measured in these 
studies, to what extent CO contributed to the maintenance of MAP during PEMI is 
unknown.  The conflicting results of the present study and those from Farquhar and 
colleagues is potentially due to differences in exercise intensity and the muscle group in 
which the reflex was evoked.  For example, CO responses are often seen during PEMI 
following more intense exercise, whereas with PEMI following lower intensity exercise 
the pressor response occurs primarily via peripheral vasoconstriction (19; 30; 32; 144).  
In our model we robustly activated the metaboreflex, whereas Farquhar and colleagues 
elicited the reflex only during 30-40% MVC.  Moreover, as opposed to evoking the reflex 
from one arm, we engage the reflex from both hindlimb muscles during full body 
dynamic exercise.  In general, with PEMI following leg exercise, HR and CO remain 
elevated, while with PEMI following moderate arm exercise there is little HR or CO 
response (5; 45; 123).  Therefore, it is possible that the experimental model of Farquhar 
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and colleagues is one that is driven by peripheral vasoconstriction and not CO.  Indeed 
previous studies both support (19; 30-32; 123; 132; 144; 150) and refute (16; 32; 123) 
any role for CO in mediating the pressor response during PEMI.  As such, we would not 
expect the pressor response to fall during PEMI in HTN as in our model. 
Contrary to our hypothesis, we did not observe a vasoconstriction-mediated 
pressor response during PEMI in HTN.  Following induction of HTN, there was a 
marked downward baseline shift in NIVC during all settings indicating enhanced 
peripheral vasoconstriction, however the recovery pattern of NIVC during PEMI was 
similar to control indicating no increase in peripheral vasoconstriction.  In the present 
study, and a few previous studies (14; 27; 28; 83), we observed a small, but significant 
increase in NIVC with metaboreflex activation.  We have concluded from preliminary 
data that this significant increase in peripheral vascular conductance is due to a 
metaboreflex-induced release of epinephrine from the adrenal glands mediating a β2-
mediated vasodilation (80).  The rise in NIVC with metaboreflex activation after 
induction of HTN was blunted.  Whether this is due to reduced epinephrine release, 
fewer beta receptors or enhanced sympathetic α1-mediated vasoconstriction opposing 
the β2-mediated vasodilation is unknown. 
In summary, we previously demonstrated in normal subjects that CO sustains the 
pressor response during PEMI.  Following induction of HTN, metaboreflex-induced CO 
and HR responses were markedly attenuated and the mechanisms sustaining the 
pressor response during PEMI were altered as CO and HR fell to normal recovery 
levels. Moreover, the recovery pattern of NIVC during PEMI was similar to control 
indicating no increase in peripheral vasoconstriction.  Therefore, the attenuated pressor 
response was not sustained during PEMI in HTN.  
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CHAPTER 4 
Exaggerated Coronary Vasoconstriction Limits Muscle Metaboreflex-Induced 
Increases in Ventricular Performance in Hypertension 
Abstract 
Increases in myocardial oxygen consumption mainly occur via increases in 
coronary blood flow (CBF) inasmuch as cardiac oxygen extraction is high even at rest.  
However, during exercise, sympathetically-mediated constrictor tone can limit increases 
in CBF.  Increased sympathetic nerve activity (SNA) during exercise may stem from 
muscle metaboreflex activation (MMA).  SNA is often elevated even at rest in subjects 
with hypertension (HTN).  We tested whether HTN causes exaggerated coronary 
vasoconstriction during mild treadmill exercise with MMA (imposed via reducing 
hindlimb blood flow by ~60%) which thereby limits increases in CBF and ventricular 
performance.  Experiments were repeated after α1-adrenergic blockade (prazosin; 75 
µg/kg) and in the same animals following induction of HTN (Goldblatt 2K1C model).  
HTN increased mean arterial pressure from 97.1 ± 2.6 to 132.1 ± 5.6 mmHg at rest and 
MMA-induced increases in CBF, left ventricular dP/dtmax and cardiac output were 
markedly reduced to only 32 ± 13%, 26 ± 11% and 28 ± 12% of the changes observed 
in control.  In HTN, α1-adrenergic blockade restored the coronary vasodilation and 
increases in ventricular function to the levels observed when normotensive.  We 
conclude that in HTN, exaggerated MMA-induced increases in SNA functionally 
vasoconstrict the coronary vasculature impairing increases in CBF which limits oxygen 
delivery and ventricular performance.  
Introduction 
When oxygen demand of working skeletal muscle exceeds oxygen supply the 
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muscle releases metabolites (e.g., hydrogen ion (21; 157), potassium ion (95), 
diprotonated phosphate (21; 146), lactate (34; 86; 128; 143; 147) and ATP (62; 91; 
153)) which stimulate metabolically-sensitive group III/IV afferents (3; 7; 24; 86; 102; 
128).  This reflexively increases sympathetic outflow from the brainstem – termed the 
muscle metaboreflex (20).  When engaged during submaximal dynamic exercise, the 
metaboreflex increases heart rate (HR) and ventricular contractility resulting in large 
increases in cardiac output (CO) and mean arterial pressure (MAP) (4; 11; 31; 38; 94; 
116; 132; 150; 163).  The rise in CO is driven by marked increases in HR (5; 31; 43; 67; 
114; 138; 163) coupled with a sustained or slight increase in stroke volume (SV) (27; 
31; 116; 138; 144; 150) which is supported via enhanced ventricular contractility 
(dP/dtmax) (27; 30; 68; 116; 138), lusitropy (dP/dtmin) (68; 150) and central blood volume 
mobilization (CBVM) (140).  This increase in CO is the primary mechanism mediating 
the rise in arterial blood pressure as little if any net peripheral vasoconstriction is 
observed (14; 30; 59; 68; 144; 150; 163).  Therefore, the muscle metaboreflex has been 
described as a flow-sensitive, flow-raising reflex (120) that works to improve oxygen 
supply to the ischemic working muscle (117). 
During exercise, the increased cardiac oxygen demand is met primarily via 
increases in CBF inasmuch as oxygen extraction is already ~80% even at rest (37; 40; 
156).  The rise in CBF is achieved via coronary metabolic and feed-forward, β2-
adrenergic vasodilation (37; 40; 156) which is restrained by the vasoconstrictor actions 
of the rise in cardiac SNA (57).  Muscle metaboreflex activation increases CBF solely 
via the large increase in MAP; despite large increases in cardiac work (greater CO 
pumped against a higher afterload), no coronary vasodilation occurs due to enhanced 
α1-adrenergic-mediated coronary vasoconstriction (10; 27; 119).  Blockade of the 
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constrictor tone increases CBF during muscle metaboreflex activation resulting in 
improved ventricular performance and CO (27; 28; 119).  
Resting SNA is heightened in hypertension (HTN) (51; 54; 72; 97; 101; 105; 
155).  Moreover, an enhanced sympathetically-mediated coronary constrictor tone and 
restrained coronary metabolic vasodilation during dynamic exercise has been 
demonstrated in HTN (55).  Recent studies support (23; 35; 52; 106; 107; 139) and 
refute (126) accentuated muscle metaboreflex function in HTN.  Very recently, we 
reported attenuated metaboreflex-induced chronotropic and inotropic responses in HTN 
(136).  We hypothesized that enhanced coronary vasoconstriction contributes to the 
impaired ability to increase ventricular performance during muscle metaboreflex 
activation in HTN.  
Methods 
Experimental subjects.  Six mongrel canines were designated for the study.  All 
animals were healthy, adult, female, ~20-25 kg in body weight, acclimatized to the 
laboratory surroundings and willing to run on a motor-driven treadmill.  During 
experimentation, all animals exercised voluntarily and no negative reinforcement 
techniques were utilized.  The protocols developed and employed in the present study 
were approved by the Institutional Animal Care and Use Committee (IACUC) of Wayne 
State University and complied with the National Institutes of Health Guide to the Care 
and Use of Laboratory Animals.   
Surgical procedures.  Each animal was completely instrumented with chronic, 
indwelling cardiovascular devices following two sterile surgical procedures: left 
thoracotomy followed by a left flank retroperitoneal surgery.  The animals recovered a 
minimum of ten days prior to the second surgery and a minimum of seven days prior to 
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the first experiment.  During preoperative care, the animals were initially sedated with 
acepromazine (0.4-0.5 mg/kg IM).  Following adequate sedation, the animals were 
anesthetized with a combined treatment of ketamine and diazepam (5.0 and 0.22 mg/kg 
IV, respectively).  Anesthesia was maintained with isoflurane gas (1-3%) following 
endotracheal intubation.  In addition, the animals received preoperative administration 
of cefazolin (antibiotic, 30 mg/kg IV), carprofen (analgesic, 2.0 mg/kg IV), buprenorphine 
(analgesic, 0.01 mg/kg IM) and fentanyl (analgesic, 125–175 µg/h (72h) TDD).  Prior to 
the left thoracotomy, animals received selective intercostal nerve blockade with 
bupivacaine HCL (2.0 mg/kg).  Following each surgical procedure, animals received 
cefazolin (30 mg/kg IV) and prophylactic cephalexin (antibiotic, 30 mg/kg (BID) PO) 
therapy for the term of the experimental protocol.  During the 12h postoperative period, 
animals were closely monitored and received buprenorphine and acepromazine (0.05 
and 0.5 mg/kg IV, respectively) as needed to control any potential discomfort.  For the 
following 10 days, animals received carprofen (4 mg/kg (OPD) PO). 
In the first surgical procedure, the thoracic cavity was opened via a left 
thoracotomy (4th intercostal space) approach.  The pericardium was cut and reflected to 
expose the heart.  An ultrasonic perivascular flow probe (20PAU, Transonic Systems) 
was positioned around the ascending aorta to measure CO.  Approximately 10 cm 
caudal to the thoracotomy incision, an implantable telemetry blood pressure transmitter 
(TA11 PA-D70, Data Sciences International) was tethered subcutaneously.  The 
catheter of the transmitter was tunneled into the thoracic cavity through the 7th 
intercostal space and the tip was inserted and secured inside the left ventricle for 
measuring left ventricular pressure (LVP).  Lastly, the left atrial appendage was 
reflected and the circumflex branch of the left coronary artery was exposed.  An 
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ultrasonic perivascular flow probe (3PSB, Transonic Systems) was positioned around 
the circumflex artery to measure coronary blood flow (CBF).  The pericardium was 
loosely re-approximated, the cables were tunneled subcutaneously and exteriorized 
between the scapulae and the chest was closed in layers.   
In the second surgical procedure, an incision was made in the left flank cranial to 
the iliac crest.  The abdominal aorta was exposed and an ultrasonic perivascular flow 
probe (10PAA, Transonic Systems) was positioned around it for measuring hindlimb 
blood flow (HLBF).  All side branches of the terminal aorta, between the common iliacs 
and the flow probe, were ligated and severed.  In addition, two perivascular hydraulic 
occluders (8-10 mm, DocXS Biomedical Products) were positioned around the terminal 
aorta (distal to the flow probe) to provide the means to incrementally reduce HLBF.  A 
19-gauge polyvinyl catheter (Tygon, S54-HL, Norton) was advanced through a ligated 
lumbar artery and secured into the terminal aorta cranial to the probe and occluders to 
measure arterial pressure.  Lastly, the left renal artery was exposed and an ultrasonic 
perivascular flow probe (4PSB, Transonic Systems) was positioned around the vessel 
to measure renal blood flow (RBF).  A perivascular hydraulic occluder (4-6 mm, DocXS 
Biomedical Products) was positioned around the renal artery (distal to the flow probe) to 
provide the means to reduce RBF.  The cables and vascular occluder tubing were 
tunneled subcutaneously and exteriorized between the scapulae and the abdomen was 
closed in layers. 
Data acquisition.  After complete postoperative recovery, each animal was 
brought into the laboratory and allowed to roam freely and acclimate for approximately 
15-20 minutes.  Following this period, the animal was directed onto the treadmill where 
its instrument cables and tubing were unpacked and prepared for data collection.  The 
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CO, RBF, CBF and HLBF flow probe cables were connected to transit-time perivascular 
flow meters (TS420, Transonic Systems).  The LVP transmitter was turned on and the 
signal was collected via telemetry (Data Sciences International).  The arterial catheter 
was aspirated, flushed and connected to a pressure transducer (Transpac IV, ICU 
Medical).  All aforementioned hemodynamic variables, in addition to MAP (calculated) 
and HR (triggered by the CO signal), were monitored as beat-by-beat averages and 
real-time waveforms by a data acquisition system (LabScribe, iWorx) and recorded for 
subsequent off-line analysis.  
Induction of hypertension.  HTN was induced via a modified Goldblatt (2K1C) 
model (48).  After competition of control experiments, blood flow to the left kidney was 
reduced to a target level of ~30% of baseline via partial inflation of the renal vascular 
occluder.  The level of RBF was checked at least 2x/day and the vascular occluder 
adjusted until flow was stable.  HTN gradually developed over the next several weeks.  
We defined HTN as a systolic pressure ≥ 140 mmHg and a diastolic pressure ≥ 90 
mmHg.  The experiments were repeated after 34.4 ± 1.6 days of sustained HTN.  Thus, 
the experiments were longitudinal in nature as each animal served as its own control. 
Experimental procedures.  Both control and experimental procedures began with 
the animal standing unrestrained and still on the treadmill until all resting hemodynamic 
data were observed to be stable (typically 5-10 min).  The treadmill was turned on and 
the speed was gradually increased to 3.2 km/h at 0% grade (mild exercise for a canine).  
Steady-state was generally reached within 3-5 minutes.  The muscle metaboreflex was 
engaged via partial reductions in HLBF during mild, dynamic exercise.  
Data analysis. CO, CBF, HLBF, RBF, LVP, HR and MAP data were continuously 
recorded during each experimental procedure.  Other hemodynamic parameters were 
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calculated during off-line data analysis (e.g., stroke volume (SV), dP/dtmax, dP/dtmin, total 
peripheral resistance (TPR), non-ischemic vascular conductance (NIVC), coronary 
vascular conductance (CVC) and cardiac power (CP)).  TPR, NIVC, CVC and CP were 
calculated as (MAP/CO), [(CO-HLBF)/MAP], CBF/MAP and [(MAPxCO)/451] (42), 
respectively.  Due to technical difficulties, we were only able to obtain dP/dtmax data for 
five animals.  One minute averages of steady-state data were calculated at rest, during 
exercise and during metaboreflex activation.  Mean values were averaged across all 
animals to obtain the population mean of the study.  
For slope analysis (Figure 4.5, left panel), all data points were fitted to two linear 
regression lines (initial response and metaboreflex-induced response lines) and three 
points were used to characterize the responses: free-flow exercise (mild exercise with 
no reduction in HLBF), threshold (intersection of the two linear regression lines) and 
max (maximal metaboreflex-induced response at lowest imposed level of HLBF).  For 
Figure 4.7, a straight line was ascribed (via least squares linear regression analysis) to 
all data points (i.e., all graded reductions) between and including free-flow exercise and 
max (from left to right, respectively) for each of the four conditions.  In Figure 4.8, the 
ratio of the changes in CVC and CP from free-flow exercise to max (i.e., ∆CVC:∆CP) 
were calculated for each of the four conditions.  For Figure 4.9, a straight line was 
ascribed (via least squares linear regression analysis) to all data points: rest, free-flow 
exercise and max (from left to right, respectively) for each of the four conditions. 
Statistical analysis.  Averaged responses for each animal were analyzed with 
Systat software (Systat 11.0).  A P < 0.05 was set to determine statistical significance.  
A two-way repeated measures ANOVA was used to compare hemodynamic data for 
time and/or conditional effects.  In the event of a significant time-condition interaction, a 
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C-matrix test for simple effects was performed.  Data are reported as means ± SE.  
Results 
Resting MAP and TPR were significantly elevated while CO was unaffected 
following induction of HTN (Table 4.1). 
Table 4.1. MAP, CO and TPR (mmHg, l/min and mmHg/l/min ± SE, respectively) at rest 
in the same animals before (normal) and after induction of hypertension. 
 
 
 
 
Rest  97.1 ± 2.6  3.44 ± 0.18 28.7 ± 1.9 132.1 ± 5.6* 3.56 ± 0.17 37.6 ± 2.4* 
 
Average steady-state MAP, HR, SV, CO and NIVC (Figure 4.1) and CBF, CVC, 
dP/dtmax and CP (Figure 4.2) values are shown during rest, mild exercise and muscle 
metaboreflex activation in control and after α1-adrenergic blockade in normal animals 
and in the same animals after induction of HTN. 
Normal: control vs. α1-adrenergic blockade.  In control, HR, CO, NIVC, CBF, 
CVC, dP/dtmax and CP increased from rest to exercise, while MAP and SV remained 
unchanged.  Metaboreflex activation elicited increases in all cardiovascular parameters.  
Following α1-adrenergic blockade, resting MAP and SV were lower, HR and CVC were 
higher and CO, NIVC, CBF, dP/dtmax and CP were similar with respect to control.  MAP, 
HR, CO, NIVC, CBF, CVC, dP/dtmax and CP increased from rest to exercise, while SV 
remained unchanged.  Metaboreflex activation increased all cardiovascular parameters.  
MAP and SV were lower, HR, CO, NIVC CBF, CVC and dP/dtmax were higher and CP 
was similar with respect to control during metaboreflex activation.  
MAP MAPTPR TPRCOCO 
Normal Hypertension
* - p<0.05 between normal and hypertension.
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Figure 4.1. Average steady-state mean arterial pressure (MAP), heart rate (HR), stroke
volume (SV), cardiac output (CO) and non-ischemic vascular conductance (NIVC)
values during rest, mild exercise (EX) and muscle metaboreflex activation (MMA) in
control (filled bars) and after α1-adrenergic blockade (striped bars) in the same animals
before (normal) and after induction of hypertension. * - p<0.05 between control and α1-
adrenergic blockade; † - p<0.05 from previous setting. 
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Hypertension: control vs. α1-adrenergic blockade.  In HTN, HR, CO, NIVC, CBF, 
CVC, dP/dtmax and CP increased from rest to exercise, while MAP and SV remained 
unchanged.  Metaboreflex activation elicited increases in MAP, HR, CO, NIVC, CBF, 
dP/dtmax and CP, but did not affect SV and CVC.  Following α1-adrenergic blockade, 
resting MAP was lower, NIVC was higher and HR, SV, CO, CBF, CVC, dP/dtmax and CP 
were similar with respect to control.  HR, CO, NIVC, CBF, CVC and CP increased from 
rest to exercise, while MAP, SV and dP/dtmax remained unchanged.  Metaboreflex 
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Figure 4.2. Average 
steady-state coronary 
blood flow (CBF), 
coronary vascular 
conductance  (CVC), 
dP/dtmax and cardiac 
power (CP) values during 
rest, mild exercise (EX) 
and muscle metaboreflex 
activation (MMA) in 
control (filled bars) and 
after α1-adrenergic 
blockade (striped bars) in 
the same animals before 
(normal) and after 
induction of hypertension. 
* - p<0.05 between 
control and α1-adrenergic 
blockade; † - p <0.05 from 
previous setting. 
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activation increased MAP, HR, CO, NIVC, CBF, CVC, dP/dtmax and CP, but did not 
affect SV.  HR, CO, NIVC, CBF, CVC, dP/dtmax and CP were higher, SV lower and MAP 
similar with respect to control during metaboreflex activation.   
 
Figure 4.3.  Average steady-state changes in MAP, HR, SV, CO and NIVC from rest to
mild exercise (EX) and mild exercise to muscle metaboreflex activation (MMA) in control
(filled bars) and after α1-adrenergic blockade (striped bars – prazosin (PZ)) in the same
animals before (normal) and after induction of hypertension. * - p<0.05 between control
and prazosin; # - p<0.05 between normal and hypertension. 
Normal Hypertension 
REST EX EX MMA REST EX EX MMA 
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Average steady-state changes in MAP, HR, SV, CO and NIVC (Figure 4.3) and 
CBF, CVC, dP/dtmax and CP (Figure 4.4) are shown from rest to mild exercise and mild 
exercise to muscle metaboreflex activation in control and after α1-adrenergic blockade 
in normal animals and in the same animals after induction of HTN.  
 
 
 
Normal: control vs. α1-adrenergic blockade.  Increases in MAP, HR, SV, CO, 
NIVC, CBF, dP/dtmax and CP from rest to mild exercise were not significantly affected by 
α1-adrenergic blockade, however CVC was significantly augmented.  From mild 
exercise to metaboreflex activation, the rise in MAP was attenuated, CO, NIVC, CBF, 
CVC and dP/dtmax were augmented and HR, SV and CP were not significantly affected 
following α1-adrenergic blockade. 
Hypertension: control vs. α1-adrenergic blockade.  Increases in all cardiovascular 
parameters from rest to mild exercise were not significantly affected by α1-adrenergic 
blockade.  From mild exercise to metaboreflex activation, the rise in HR, CO, NIVC, 
CBF, CVC, dP/dtmax and CP were augmented and MAP and SV were not significantly 
affected following α1-adrenergic blockade.  
Normal vs. hypertension.  Increases in NIVC from rest to exercise in normal 
animals was significantly lower in the same animals following induction of HTN.  
Figure 4.4.  Average steady-state changes in CBF, CVC, dP/dtmax and CP from rest to
mild exercise (EX) and mild exercise to muscle metaboreflex activation (MMA) in control
(filled bars) and after α1-adrenergic blockade (striped bars – prazosin (PZ)) in the same
animals before (normal) and after induction of hypertension. * - p<0.05 between control
and prazosin; # - p<0.05 between normal and hypertension. 
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Metaboreflex-induced increases in MAP, HR, SV, CO, NIVC, CBF, dP/dtmax and CP 
were significantly attenuated following induction of HTN, while CVC was unaffected.  
Following α1-adrenergic blockade, increases in MAP, HR, CO, NIVC, CBF, CVC, 
dP/dtmax and CP from mild exercise to metaboreflex activation were not any different 
from normal levels following α1-adrenergic blockade. 
Figure 4.5 (left panel) shows stimulus-response relationships for MAP, CO, HR, 
CBF, CVC and dP/dtmax during free-flow exercise, threshold and max, from right to left, 
respectively.  Data were collected following graded reductions in HLBF during mild 
exercise in control and after α1-adrenergic blockade in normal animals and in the same 
animals after induction of HTN.  The slopes of the metaboreflex-response lines are 
indicative of the gain of the metaboreflex for each individual cardiovascular parameter.  
Figure 4.5 (right panel) shows the changes in the slopes of the metaboreflex-induced 
response   lines   for   MAP,  CO,   HR,   CBF,   CVC and  dP/dtmax in  control  and  after 
 
55 
 
  
 
Hindlimb Blood Flow 
(l/min)
0.0 0.5 1.0 1.5 2.0
Hindlimb Blood Flow 
(l/min)
0.0 0.5 1.0 1.5 2.0
dP
/d
t m
ax
(m
m
H
g/
se
c)
1500
2500
3500
4500
C
or
. V
as
c.
 C
on
d.
(m
l/m
in
/m
m
H
g)
0.2
0.4
0.6
0.8
C
or
. B
lo
od
 F
lo
w
(m
l/m
in
)
20
40
60
80
100
H
ea
rt
 R
at
e
(b
ea
ts
/m
in
)
100
125
150
175
200
225
C
ar
di
ac
 O
ut
pu
t
(l/
m
in
)
4
6
8
10
NORMAL
M
ea
n 
A
rt
. P
re
ss
.
(m
m
H
g)
80
100
120
140
160
180
HYPERTENSION NORMAL
M
ea
n 
Ar
t. 
Pr
es
s.
(m
m
H
g/
l/m
in
) -200
-150
-100
-50
0
HYPERTENSION
C
ar
di
ac
 O
ut
pu
t
(l/
m
in
/l/
m
in
)
-20
-15
-10
-5
0
H
ea
rt
 R
at
e
(b
pm
/l/
m
in
)
-400
-300
-200
-100
0
C
or
. B
lo
od
 F
lo
w
(m
l/m
in
/l/
m
in
) -250
-200
-150
-100
-50
0
C
or
. V
as
c.
 C
on
d.
(m
l/m
in
/m
m
H
g/
l/m
in
)
-1.25
-1.00
-0.75
-0.50
-0.25
0.00
N PZ
dP
/d
t m
ax
(m
m
H
g/
se
c/
l/m
in
)
-8000
-6000
-4000
-2000
0
HTN PZ
#
*
#
* #
*
#
*
*
#
*
*
#
*
#
*
*
Figure 4.5.  (Left panel) Stimulus-response relationships for MAP, CO, HR, CBF, 
CVC and dP/dtmax as a function of graded reductions in hindlimb blood flow (HLBF).  
Data plotted are free-flow exercise, threshold and max (from right to left, respectively) 
in control (solid lines/filled symbols) and after α1-adrenergic blockade (dashed 
lines/open symbols) in the same animals before (normal) and after induction of 
hypertension.  (Right panel) Changes in the slopes of the metaboreflex-induced 
response lines for MAP, CO, HR, CBF, CVC and dP/dtmax in control (filled bars) and 
after α1-adrenergic blockade (striped bars – prazosin (PZ)) in the same animals 
before (normal) and after induction of hypertension. * - p<0.05 between control and 
prazosin; # - p <0.05 between normal and hypertension. 
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α1-adrenergic blockade in normal animals and in the same animals after induction of 
HTN.  Following α1-adrenergic blockade, the slopes of the metaboreflex-induced 
response lines for CO, HR, CBF, CVC and dP/dtmax were significantly higher while MAP 
was unchanged.  These slopes were significantly lower for all cardiovascular 
parameters following induction of HTN, while α1-adrenergic blockade fully restored the 
slopes (except CO; p=0.042) to normal levels following α1-adrenergic blockade. 
The relationship between CVC and CP in one animal is shown in Figure 4.6.  A 
straight line was ascribed from rest to free-flow exercise.  Linear regression analysis 
was used fit a straight line through free-flow exercise and all subsequent reductions in 
HLBF.  The relationship from rest to max was exceedingly nonlinear.  Therefore, resting 
data were excluded and a straight line was ascribed to the remaining data points (i.e., 
free-flow exercise and all HLBF reductions) via linear regression analysis in order to 
appropriately compare the slopes of the relationship before and after induction of HTN 
and with and without α1-adrenergic blockade (Figure 4.7).  
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Figure 4.7 shows the relationship between CVC and CP in control and after α1-
adrenergic blockade in normal animals and in the same animals after induction of HTN 
during rest, free-flow exercise and max (left to right, respectively).  After induction of 
HTN, the slope of the relationship (from free-flow exercise to max) was significantly 
lower and the increase in CP was markedly attenuated.  Following α1-adrenergic 
blockade, the slope of the relationship was significantly shifted upward and not any 
different than during α1-adrenergic blockade prior to induction of HTN.  Moreover, the 
increase in CP was not any different following α1-adrenergic blockade before and after 
induction of HTN. 
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Figure 4.7.  The relationships between CVC and CP during rest, free-flow exercise
and max (left to right, respectively) in control (solid lines/filled symbols) and after
α1-adrenergic blockade (dashed lines/open symbols) in the same animals before
(circles) and after induction of hypertension (triangles).  * - p<0.05 max CP before
and after induction of hypertension. 
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Figure 4.8 shows the ratio of the changes in CVC and CP from free-flow exercise 
to max (i.e., ∆CVC:∆CP) in control and following α1-adrenergic blockade before and 
after induction of HTN.  Following α1-adrenergic blockade, ∆CVC:∆CP was significantly 
greater than in control.  Following induction of HTN, ∆CVC:∆CP was significantly 
reduced.  Following α1-adrenergic blockade, ∆CVC:∆CP was not any different than 
during α1-adrenergic blockade prior to induction of HTN. 
 
Figure 4.9 shows the relationship between dP/dtmax and CBF in control and after 
α1-adrenergic blockade in normal animals and in the same animals after induction of 
HTN.  The slope of the relationship between dP/dtmax and CBF was exceedingly linear 
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Figure 4.8.  Ratio of changes in CVC and CP from free-flow exercise to max (i.e.,
∆CVC:∆CP) in control (filled bars) and following α1-adrenergic blockade (striped
bars) in the same animals before (normal) and after induction of hypertension.  * -
p<0.05 between control and α1-adrenergic blockade; † - p <0.05 between normal
and hypertension. 
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with all data points considered.  After induction of HTN, metaboreflex-induced increases 
in both dP/dtmax and CBF were significantly attenuated.  However, metaboreflex-induced 
increases in both dP/dtmax and CBF were not any different following α1-adrenergic 
blockade before and after induction of HTN. 
 
Discussion 
Our major new findings are that after induction of HTN, increases in CBF during 
metaboreflex activation are attenuated and the ability to increase ventricular contractility 
is reduced.  Blockade of α1-adrenergic receptors restored the increases in CBF and 
ventricular function to normal levels indicating that the primary mechanism mediating 
the impaired metaboreflex-induced increases in ventricular function in HTN is coronary 
vasoconstriction.  Inasmuch as metaboreflex-induced increases in CO and MAP are 
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Figure 4.9.  Relationship between dP/dtmax and CBF in control (filled symbols) and
after α1-adrenergic blockade (open symbols) in the same animals before (normal)
(circles) and after induction of hypertension (triangles).   
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also attenuated in HTN, the ability of the reflex to restore blood flow to ischemic working 
muscle is also likely impaired which may contribute to exercise intolerance.  Moreover, 
coronary vasoconstriction during exercise in HTN may produce adverse cardiovascular 
events (e.g., coronary vasospasms, arrhythmias and myocardial ischemia). 
The increase in myocardial oxygen demand during submaximal dynamic 
exercise is principally met by increases in CBF inasmuch as myocardial oxygen 
consumption is highly blood flow dependent since oxygen extraction is already near 
maximal at rest (37; 40; 156).  The rise in CBF is largely mediated by coronary 
metabolic vasodilation (while ~25% of coronary vasodilation is feed-forward, β2-
adrenergic-mediated) as there is little increase in MAP (49).  At the same time, the rise 
in cardiac SNA with exercise limits coronary vasodilation as it activates vascular α1-
adrenergic receptors inducing a coronary constrictor tone (15; 33; 57; 65; 110; 154).  
Gwirtz et al. demonstrated an α1-adrenergic-mediated coronary constrictor tone during 
dynamic exercise in normal animals (57) and in animals with renovascular HTN (55).  
Moreover, a coronary constrictor tone during exercise has also been shown to attenuate 
increases in CBF (56; 57; 65; 84; 110), myocardial oxygen delivery (65), ventricular 
function (27; 56; 57; 84) and CO (27; 84).  Paradoxically, it has been demonstrated that 
this constrictor tone plays a beneficial role in redistributing left-ventricular CBF from the 
epicardium to the more metabolically-challenged subendocardium (41; 66).  Clearly, 
whether or not the presence of a coronary constrictor tone during exercise in normal 
individuals is advantageous or merely a cardiac-limiting consequence of elevated SNA 
during exercise remains debatable.  
Following muscle metaboreflex activation, substantial increases in cardiac SNA, 
CO and afterload intensify cardiac work (4; 114; 116; 119; 132; 158; 159; 163).  In this 
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setting, myocardial oxygen demand is met by increases in CBF which are solely driven 
by increases in MAP as no coronary vasodilation is observed (10; 27; 119).  In fact, 
Coutsos et al. (27) reported an α1-adrenergic-mediated functional coronary 
vasoconstriction with metaboreflex activation during exercise as metaboreflex-mediated 
increases in CVC and CBF markedly improved following α1-adrenergic blockade.  
Metaboreflex activation in heart failure, coupled with attenuated coronary vasodilation 
due to a decrease in cardiac work, leads to frank coronary vasoconstriction (28).  
Therefore, during muscle metaboreflex activation, there is a “push-pull” dynamic for the 
control over coronary tone.  It is likely that with the increase in cardiac work, coronary 
vasodilation is opposed by α1-adrenergic-mediated coronary vasoconstriction. 
Is muscle metaboreflex function attenuated in HTN?  While few studies have 
investigated the effects of HTN on metaboreflex control of cardiovascular function, most 
report that its function is accentuated (35; 52; 89; 106; 107; 139; 148) rather than 
attenuated (126).  We analyzed the gain (or strength) of metaboreflex-mediated 
cardiovascular responses in HTN by determining the slope of the metaboreflex-induced 
response line for each parameter we measured.  After induction of HTN, the slopes 
were significantly lower for all cardiovascular parameters (Figure 4.5) indicating that 
metaboreflex function is attenuated in HTN.  However, following α1-adrenergic blockade 
the slopes of all metaboreflex-induced response lines (except CO; p=0.042) were fully 
restored to the levels observed in control experiments following α1-adrenergic blockade.  
These data suggest that chronotropic and inotropic function are attenuated during 
metaboreflex activation in HTN due to a restriction in CBF stemming from exaggerated 
coronary constrictor tone, not an attenuation in metaboreflex function per se nor any 
inherent reduction in intrinsic myocardial function (e.g., heart failure). 
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While changes in CBF can directly influence ventricular function, changes in 
ventricular function can indirectly influence CBF via changes in coronary metabolic 
vasodilation.  As an increase in perfusion pressure can increase CBF independent of 
any change in coronary vasomotor tone (10), the extent of coronary vasodilation can 
only accurately be determined by calculating changes in conductance (or 
resistance)(113).  Feigl and colleagues (49; 50) have shown the utility of quantifying 
coronary vasodilation as a function of myocardial oxygen consumption.  As in our 
previous studies (27; 28), we used cardiac power (CP) which is well correlated to 
myocardial oxygen consumption (81).  In normal animals, CVC increased from rest to 
exercise and a small further increase occurred with metaboreflex activation similar to 
the response observed previously (with exception of the small increase in CVC which 
was not statistically significant in our previous study).  After induction of HTN, the slope 
of the relationship (from free-flow exercise to max) was significantly lower and the 
increase in CP was markedly attenuated indicating attenuated myocardial oxygen 
delivery as a result of a restrained coronary vasodilation.  Following α1-adrenergic 
blockade, the slope of the relationship was significantly shifted upward and not any 
different than during α1-adrenergic blockade prior to induction of HTN.  Moreover, the 
increase in CP was not any different following α1-adrenergic blockade before and after 
induction of HTN.  The findings demonstrate that attenuation of metaboreflex-induced 
increases in CP are largely, if not solely, dependent on heightened α1-adrenergic-
mediated coronary vasoconstriction in HTN. 
The ∆CVC:∆CP relationship was significantly lower after induction of HTN.  As 
the rise in CP with metaboreflex activation is smaller in HTN, this would tend to increase 
∆CVC:∆CP.  Therefore, it is clear that the significant decrease in ∆CVC:∆CP following 
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induction of HTN is due to a decrease in the rise in CVC with metaboreflex activation.  
The ∆CVC:∆CP relationship (from free-flow exercise to max) in HTN was significantly 
greater following α1-adrenergic blockade and was not any different than during α1-
adrenergic blockade prior to induction of HTN.  This suggests that the rise in CVC with 
metaboreflex activation is markedly restrained in HTN and that this exaggerated 
coronary vasoconstriction can be ameliorated following α1-adrenergic blockade.  
An increase in CBF can improve ventricular function via an increase in 
myocardial oxygen delivery (112).  To analyze the relationship between ventricular 
function and coronary perfusion, we plotted dP/dtmax versus CBF (Figure 4.8).  This 
relationship was exceptionally linear.  After induction of HTN, metaboreflex-induced 
increases in both dP/dtmax and CBF were significantly attenuated, without any change in 
the slope of the relationship.  Following α1-adrenergic blockade, metaboreflex-induced 
increases in dP/dtmax and CBF were restored to the same levels following α1-adrenergic 
blockade prior to induction of HTN.  These data support hypothesis that exaggerated 
coronary vasoconstriction in HTN with metaboreflex activation restrains coronary 
perfusion thereby limiting myocardial oxygen delivery and increases in ventricular 
function.  While the highly linear relationship between dP/dtmax and CBF suggests that 
ventricular function is intimately dependent on changes in CBF, the fact that the slope of 
this relationship did not change after induction of HTN suggests that most, if not all, of 
the ventricular impairment observed in this study was solely due to exaggerated 
coronary vasoconstriction, not myocardial dysfunction per se.  Coutsos et al. (28) 
reported that exaggerated metaboreflex-mediated coronary vasoconstriction attenuates 
the rise in CBF and impairs increases in ventricular function in a heart failure model.  
Furthermore, they demonstrated that this impairment in ventricular function was partially 
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ameliorated following α1-adrenergic blockade.  They concluded that the impaired 
ventricular function in heart failure was due to both intrinsic ventricular dysfunction as 
well as exaggerated coronary vasoconstriction.  
The pathology of HTN is wide-ranging.  Structural and/or functional changes 
have been well documented in the heart and the vasculature (122).  Moreover, 
alterations in arterial baroreflex (22; 53; 73; 109; 149; 164; 164) and muscle 
metaboreflex function (35; 52; 89; 106; 107; 126; 136; 139; 148) as well as brainstem 
processing of this reflex information has been demonstrated (53).  The attenuation of 
chronotropic and inotropic function after induction of HTN observed in the present study 
is clearly not due to overt pathology of the heart and the vasculature as α1-adrenergic 
blockade fully restored chronotropic and inotropic function to the same levels observed 
after α1-adrenergic blockade prior to induction of HTN.  The arterial baroreflex buffers 
muscle metaboreflex-mediated pressor responses by attenuating its capacity to 
increase peripheral resistance by constricting the peripheral vasculature (82; 142).  
There are reports of reduced baroreflex function in HTN (73; 109; 149; 164), however, 
to the best of our knowledge, there are no studies demonstrating accentuated 
baroreflex function.  Therefore, it is unlikely that the attenuated cardiovascular 
responses reported in the present study are a result of exaggerated arterial baroreflex 
buffering of the muscle metaboreflex.  Moreover, Smith et al. (148) demonstrated that 
impaired baroreflex function in HTN has little, if any, effect on skeletal muscle reflex 
function.  Dysfunctional metaboreflex afferent signal processing could at least partially 
explain the attenuated reflex-mediated increases in cardiovascular function, however 
data suggest that metaboreceptors are actually sensitized in HTN (106).  While we did 
not study β-adrenergic function in the present study, studies have demonstrated 
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impaired cardiac responses potentially stemming from reduced β-adrenergic receptor 
function (18; 165) and density (103).  
Potential limitations.  By chance and availability, all animals in the present study 
were female.  Data were not collected from animals during estrus.  Our group (88) has 
shown that in dogs muscle metaboreflex function is not influenced by gender.  
Systemic α1-adrenergic blockade can alter loading conditions as it reduces total 
peripheral resistance.  Gwirtz and colleagues (36; 56; 84) administered prazosin via the 
intracoronary route.  However, results from such studies on changes in ventricular 
function following α1-adrenergic blockade are limited to the particular segment of the left 
ventricle infused with drug.  In the present study, we were interested in the effects of α1-
adrenergic blockade on global left-ventricular function, and therefore we infused 
prazosin systemically.  We employed a selective α1-adrenergic blocker, as α2-
adrenergic receptor blockade has negligible effects on coronary vasomotor tone during 
exercise (33; 154).  Following α1-adrenergic blockade in normal animals, MAP was 
lower at rest, during exercise and during exercise with metaboreflex activation with 
respect to control.  After induction of HTN in the same animals, MAP was lower at rest 
and during exercise with respect to control.  Interestingly, during exercise with 
metaboreflex activation, MAP following α1-adrenergic blockade was not any different 
than control (likely due to the blunted rise NIVC in HTN).  Our hypothesis was that 
increases in ventricular function would be impaired due to exaggerated coronary 
vasoconstriction during metaboreflex activation in HTN.  Therefore, the major potential 
concern with systemic prazosin administration would be its effects on our index of 
contractility (dP/dtmax) as this measurement is sensitive to loading conditions.  However, 
while changes in preload can significantly affect dP/dtmax (124), changes in afterload 
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have little, if any, direct effect on this parameter (1; 70; 96; 124).  
In summary, we found that coronary vasoconstriction in HTN with metaboreflex 
activation restrains coronary perfusion and thereby limits myocardial oxygen delivery 
and increases in ventricular function during submaximal dynamic exercise.  
Accentuated coronary vasoconstriction in HTN could partially explain exercise 
intolerance and potentially precipitate adverse cardiovascular events during exercise 
such as coronary vasospasms, arrhythmias, myocardial ischemia or sudden cardiac 
death (64).  
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Skeletal muscle ischemia during or immediately following exercise leads to the 
accumulation of metabolites (e.g., lactate, proton and diprotonated phosphate) which 
activate chemoreceptive afferents within the muscle leading to a reflex increase in 
sympathetic outflow generating substantial increases in mean arterial pressure (MAP), 
cardiac output (CO) and heart rate (HR) - termed the muscle metaboreflex.  When the 
reflex is activated during submaximal dynamic exercise, the pressor response occurs 
via increased CO with no net peripheral vasoconstriction.  When metaboreflex activation 
is sustained during the recovery from exercise (i.e., post-exercise muscle ischemia – 
(PEMI)), whereas MAP remains elevated for as long as the ischemia is maintained, HR 
precipitously declines towards resting levels drawing into question the role of CO in 
supporting the pressor response.  When the reflex increase in CO is attenuated (e.g., in 
heart failure), heightened peripheral vasoconstriction supports the pressor response.  In 
hypertension (HTN), metaboreflex-mediated increases in ventricular function and CO 
are markedly attenuated during mild exercise.  As sympathetic nerve activity (SNA) is 
exaggerated in both heart failure and HTN, it is plausible that the mechanisms 
mediating the attenuation of CO in HTN with muscle metaboreflex activation are similar 
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to those previously described in heart failure.  Employing a chronically-instrumented 
canine model, data were collected from control animals and the same animal after 
induction of HTN.  We addressed three specific questions: 1) what are the 
mechanism(s) mediating the muscle-metaboreflex-induced pressor response observed 
during PEMI in normal subjects, 2) what are the mechanism(s) mediating the muscle-
metaboreflex-induced pressor response observed during PEMI in hypertensive subjects 
and 3) does metaboreflex activation during submaximal exercise in hypertensive 
animals functionally restrain coronary vasodilation further limiting increases in 
ventricular performance.  We found that: 1) the sustained increase in MAP during PEMI 
is driven by a sustained increase in CO not peripheral vasoconstriction, 2) the 
attenuated pressor response in HTN is not sustained during PEMI as HR and CO fall to 
normal recovery levels and 3) in HTN, exaggerated metaborelfex-induced increases in 
SNA functionally vasoconstrict the coronary vasculature impairing increases in CBF 
which limits oxygen delivery and ventricular performance. 
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